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ABSTRACT
Bacteriocin-producing lactic acid bacteria and their isolated peptide bacteriocins are of 
value to control pathogens and spoiling microorganisms in foods and feed. Nisin is the only 
bacteriocin that is commonly accepted as a food preservative and has a broad spectrum of 
activity against Gram-positive organisms including spore forming bacteria. In this study 
nisin induction was studied from two perspectives, induction from inside of the cell and 
selection of nisin inducible strains with increased nisin induction sensitivity. The results 
showed that a mutation in the nisin precursor transporter NisT rendered L. lactis incapable 
of nisin secretion and lead to nisin accumulation inside the cells. Intracellular proteolytic 
activity could cleave the N-terminal leader peptide of nisin precursor, resulting in active 
nisin in the cells. Using a nisin sensitive GFP bioassay it could be shown, that the active 
intracellular nisin could function as an inducer without any detectable release from the 
cells. The results suggested that nisin can be inserted into the cytoplasmic membrane from 
inside the cell and activate NisK. This model of two-component regulation may be a general 
mechanism of how amphiphilic signals activate the histidine kinase sensor and would 
represent a novel way for a signal transduction pathway to recognize its signal. 
In addition, nisin induction was studied through the isolation of natural mutants of 
the GFPuv nisin bioassay strain L. lactis LAC275 using fl uorescence-activated cell sorting 
(FACS). The isolated mutant strains represent second generation of GFPuv bioassay strains 
which can allow the detection of nisin at lower levels.
The applied aspect of this thesis was focused on the potential of bacteriocins in chicken 
farming. One aim was to study nisin as a potential growth promoter in chicken feed. 
Therefore, the lactic acid bacteria of chicken crop and the nisin sensitivity of the isolated 
strains were tested. It was found that in the crop Lactobacillus reuteri, L. salivarius and L. 
crispatus were the dominating bacteria and variation in nisin resistance level of these strains 
was found. This suggested that nisin may be used as growth promoter without wiping 
out the dominating bacterial species in the crop.  As the isolated lactobacilli may serve 
as bacteria promoting chicken health or reducing zoonoosis and bacteriocin production is 
one property associated with probiotics, the isolated strains were screened for bacteriocin 
activity against the pathogen Campylobacter jejuni. The results showed that many of the 
isolated L. salivarius strains could inhibit the growth of C. jejuni. The bacteriocin of the L. 
salivarius LAB47 strain, with the strongest activity, was further characterized. Salivaricin 
47 is heat-stable and active in pH range 3 to 8, and the molecular mass was estimated to be 
approximately 3.2 kDa based on tricine SDS-PAGE analysis.
11. LACTIC ACID BACTERIA  
Lactic acid bacteria (LAB) constitute a diverse group of Gram-positive bacteria, 
characterized by some common morphological, metabolic and physiological traits. They 
are anaerobic bacteria, non-sporulating, acid tolerant and produce mainly lactic acid as 
an end product of carbohydrate fermentation. Lactic acid bacteria consist of a number of 
diverse genera which include both homofermenters and heterofermenters based on the 
end product of their fermentation.The homofermenters produce lactic acid as the major 
product of fermentation of glucose and include the genera Lactococcus, Streptococcus and 
Pediococcus. In contrast, the heterofermenters produce a number of products besides lactic 
acid, such as carbon dioxide, acetic acid, and ethanol from the fermentation of glucose and 
includes the genus Leuconostoc and a subgroup of the genus Lactobacillus, the Betabacteria 
(Jay 1986; Kandler et al. 1986; Schillinger and Lücke 1987).
Lactic acid bacteria consist of a number of bacterial genera within the phylum 
Firmicutes.  Recent taxonomic studies suggested that the LAB group includes the following 
genera; Carnobacterium, Enterococcus, Lactobacillus, Lactococcus, Lactosphaera, 
Leuconostoc, Melissococcus, Oenococcus, Pediococcus, Streptococcus, Tetragenococcus, 
Vagococcus and Weissella (Ercolini et al. 2001; Holzapfel et al. 2001; Carr et al. 2002). 
Species of these genera can be found in the GIT of man and animal as well as in fermented 
food. LAB strains used as probiotics usually belong to species of the genera Lactobacillus, 
Enterococcus or Bifi dobacterium.
Gram-positive bacteria belonging to the phylum Actinobacteria, such as the 
genera Aerococcus, Microbacterium, Propionibacterium (Sneath and Holt 2001) and 
Bifi dobacterium (Gibson and Fuller 2000; Holzapfel et al. 2001) also produce lactic acid. 
The core LAB genera Lactobacillus, Lactococcus, Leuconostoc, Pediococcus and 
Streptococcus share a long history of safe usage in the processing of fermented foods. The 
antimicrobial effects and safety of LAB in food preservation is widely accepted (EFSA, 
2005; de Vuyst and Leroy 2007; Sit and Vederas 2008). Their preservative effect is mainly 
due to the production of lactic acid and other organic acids which results in lowering of 
pH (Daeschel 1989). Preservation is enhanced by the production of other antimicrobial 
compounds, including hydrogen peroxide, CO2, diacetyl, acetaldehyde, and bacteriocins 
(Stiles and Hastings 1991; Klaenhammer 1988; 1993). 
In addition to the antimicrobial effects specifi c LAB also possess health promoting 
properties. Evidence from in vitro systems, animal models, and human clinical studies 
suggest that LAB function as immunomodulators and can enhance both specifi c and non-
specifi c immune responses (Ouwehand et al. 1998; 2002; O’Flaherty and Klaenhammer 
2009) justifying their use as health promoting supplements or probiotics both for humans 
and animals. 
1.1. Antimicrobial peptides produced by lab
Lactic acid bacteria are capable of producing a wide range of ribosomally synthesized 
proteins and peptides which have antimicrobial activity to compete with other bacteria 
of the same species (narrow spectrum) or to counteract bacteria of other genera (broad 
spectrum) (Cotter et al. 2005). The first description of bacteriocin-mediated growth 
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2inhibition was reported 85 years ago, when antagonism between strains of Escherichia 
coli was fi rst discovered (Gartia 1925). The inhibitory substances were called ‘colicins’, 
to refl ect the producer organism, whereas gene-encoded antibacterial peptides produced by 
bacteria are now referred to as ‘bacteriocins’. 
Since their initial discovery in 1925, numerous bacteriocins have been isolated from 
LAB. Continuous discovery of new bacteriocins with novel features requires an updating of 
the classifi cation of bacteriocins.
Based on a recently proposed classifi cation (Drider et al. 2006), there are three main 
classes of LAB-produced bacteriocins as shown in table (1).
 According to database BACTIBASE (Hammami et al. 2007), http://bactibase.pfba-
lab-tun.org/bacteriocinslist.php?start=1, a list of 180 entries, including 45 lanthionine-
containing bacteriocins (Class I), 55 non-lanthionine-containing bacteriocins (Class II) and 
80 other unclassifi ed entries are listed. 
Table 1. Classifi cation of LAB bacteriocins according to Drider et al. 2006.
Category  Subcategory Characteristics Examples
Class  I             
Lantibiotics, lanthionine 
containing    
Class II
Non-modifi ed heat –
stable bacteriocins         
Class III
Protein bacteriocins                    
Type A
Type  Type B 
Subclass IIa
(antilisterial pediocin-
like bacteriocins)
Subclass IIb
(two-peptide 
bacteriocins)  
                      
Subclass IIc
(other peptide 
bacteriocins)
elongated molecules: 
molecular mass <4 kDa              
globular  molecules;
molecular mass 1.8 to 2.1 
kDa    
molecular masses <10 kDa
 molecular masses
>30 kDa
Nisin
Mersacidin
Pediocin PA-1
Plantaricin EF
Lactococcin 972
Helveticin J
1.2. Impact of lab and their antimicrobial peptides in food safety and therapy 
In 2005 an estimated 1.8 million people died from diarrhoeal diseases, largely attributable 
to contaminated food and drinking water (Newell et al. 2010). About 76 million cases of 
food-borne diseases, resulting in 325,000 hospitalizations and 5000 deaths, are estimated 
to occur each year in the United States of America (USA) alone (Newell et al. 2010). In 
Finland, a total of 39 500 persons contracted food-borne illness in outbreaks during years 
1975-2006 (Niskanen et al. 2007).
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3Clearly, food and water safety need to be improved. Microbes have an extraordinary 
array of defense systems. These include classical antibiotics, metabolic by-products such 
as lactic acid, numerous types of protein exotoxins, and antimicrobial peptides such as 
bacteriocins. The most promising antimicrobial peptides are those produced by LAB. 
Most LAB bacteriocins are non-toxic to eukaryotic cells and generally recognized as safe 
substances being active in the nanomolar range (Cotter et al. 2005; Peschel and Sahl 2006). 
LAB antimicrobial peptides typically exhibit antibacterial activity against food-borne 
pathogens, as well as spoilage bacteria. Therefore, they have attracted the greatest attention 
as tools for food biopreservation (Collins et al. 1998; O’Sullivan et al. 2002; Reid et al. 
2003).
 Bacteriocins can be introduced into food in three different ways: (1) bacteriocins can 
be produced in situ in fermented food by bacterial cultures that substitute for all or part of 
the starter culture; (2) purifi ed or semi-purifi ed bacteriocins can be added directly to food; 
(3) or as an ingredient (Cotter et al.  2005; Calo-Mata et al.  2008).
The incorporation of bacteriocins as biopreservative ingredients into model 
food systems has been shown to be effective in the control of pathogenic and spoilage 
microorganisms (Leroy et al 2005; Leroy and de Vuyst 2005). Nisin is produced by L. 
lactis and has the most widespread usage and is the only bacteriocin having a status as a 
food additive designated as E234 (EEC 1983). Different strategies for the addition of LAB 
bacteriocins, especially those not accepted as food additives have been proposed. They 
may be produced ex situ and added as spent fermentation preparations or produced in situ 
in the food by bacteriocinogenic LAB. Food starters known to produce bacteriocins are 
on the market (Danisco) resulting in bacteriocin production during the food processing. 
Preparations containing nisin (commercialized in the form of Nisaplin™) or pediocin 
PA-1/AcH (commercialized in the form of ALTA2341) are commercially available. It 
may be practical and economical to incorporate bacteriocins into foods by the addition of 
bacteriocin-producing cultures for in situ production (O’Sullivan et al.  2002). Nowadays, 
antimicrobial peptide producing LAB are routinely employed as starter cultures in the 
manufacture of dairy, meat and vegetable products for increased quality and food safety 
(O’Sullivan et al. 2002). LAB have successfully been employed, at laboratory scale, as 
‘protective cultures’ to inhibit pathogenic microorganisms in a variety of food systems 
(Ryan et al. 1996; 1999; Oumer et al. 2001).
Some LAB strains also have a health promoting capacity in humans (Avonts and 
de Vuyst 2001; Avonts et al. 2004) which may be explained in part by the production of 
antibacterial peptides which inhibit the growth of pathogens. Antimicrobial activity by 
probiotic cultures has at least been demonstrated in vitro (Pridmore et al. 2008; Ryan et 
al. 2009). Support for in vivo action has been presented by Corr and others (2007) who 
demonstrated that oral intake of Lactobacillus salivarius UCC118 protected mice against 
infection with the food-borne pathogen Listeria monocytogenes, which was sensitive to the 
bacteriocin produced by the UCC118 strain. Starter cultures that offer functionalities beyond 
acidifi cation like the production of bacteriocins are being explored (Leroy and de Vuyst 
2004; de Vuyst et al. 2004; Gänzle 2009). In some countries LAB are already extensively 
used as probiotics in food processing and preservation (de Vuyst and Leroy 2007). LAB-
derived bacteriocins have been utilized as oral, topical antibiotics or disinfectants. Nisin 
is one of few examples of AMP-based antibiotic therapies that have been commercialized 
(Cotter et al. 2005; Dufour et al. 2007; Rossi et al. 2008). Nisin is used as an active agent in 
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4Wipe-Out (a teat wipe), and lacticin 3147-containing teat seals (Cross Vetpharm Group Ltd) 
have been shown to prevent infection by mastitic Staphylococci and Streptococci in animal 
challenge trials (Ryan et al. 1999). Nisin also has potential for treatment of human mastitis 
(Fernandez et al. 2008). A dietary supplement BLIS K12 throat guard, which contains 
Streptococcus salivarius K12 that produces two lantibiotics, salivaricin A2 and B, is sold 
in New Zealand as a culture for helping to maintain a healthy throat.  S. salivarius K12 is 
also reported as an inhibitor of the bacteria responsible for bad breath (Tagg et al. 2004). 
Interestingly, nisin effi ciently inhibits sperm motility, showing potential as a contraceptive 
(Aranha et al.  2004).
An antiviral peptide produced by E. faecium was fi rst reported by Wachsman et al. 
(1999). The peptide, 3.5 kDa in size, inhibited late stages of the herpes simplex (HSV-1 and 
HSV-2) multiplication cycle (Wachsman et al. 2003).
Limited data on the development and the mechanisms of bacteriocin resistance 
is available. Bacteriocin resistance is of concern for food preservation and potential 
therapeutic treatment by specifi c bacteriocins. Both Gram-positive and Gram-negative 
bacteria can develop resistance to bacteriocins. The mechanism of bacteriocin resistance 
is complex and various structural and physiological changes in the bacterial cell envelope 
can lead to resistance (Ennahar et al. 1999; Cleveland et al. 2001; Peschel and Sahl 2006; 
Sahl and Bierbaum 2008). Recently, it has been proposed that bacteriocins may have 
multiple low-affi nity targets. Therefore, it is possible that such low-affi nity interactions 
of bacteriocins with multiple targets do not promote the development of antimicrobial 
resistance explaining why bacteria have not developed effective resistance mechanisms 
towards natural AMPs, including bacteriocins (Peschel and Sahl  2006; Sahl and Bierbaum 
2008). In contrast, many therapeutic antibiotics act on a single, high-affi nity target, which 
makes it comparatively easy for bacteria to develop high-level resistance (Peschel and Sahl 
2006; Sahl and Bierbaum 2008).
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Nisin is the most characterized bacteriocin among the antimicrobial peptides produced by 
lactic acid bacteria. Nisin is the prototype of the lantibiotic group of antimicrobial peptides 
and is produced by specifi c strains of Lactococcus lactis subsp. lactis and Streptococcus 
uberis (Wirawan et al. 2006).Nisin (E243) is approved as a food preservative in over 
50 countries, and it is used particularly in processed cheese, dairy products and canned 
foods (EEC 1983; Delves-Broughton et al. 1996).The inhibitory effects of nisin and nisin-
producing L. lactis cells in food matrices are well described and have been shown to inhibit 
the growth of a wide range of gram-positive bacteria including food spoilage and pathogenic 
bacteria such as B. cereus, C. perfringens, S. aureus, and L. monocytogenes (McAuliffe 
et al. 2001).Nisin has been commercially exploited on a large scale (Delves-Broughton 
et al. 1996; Twomey et al. 2002), due to its low toxicity, stability during processing and 
storage, effi cacy at low concentration, economic viability, and the absence of deleterious 
effects on the food (Hurst 1981; O’Keeffe and Hill 2000). Moreover, this safe and natural 
food additive has been utilized recently in clinical applications as an antimicrobial agent 
against the causative bacteria of bovine mastitis, and therefore it has been incorporated 
into commercial products that are used as an alternative treatment to antibiotics (Sears et 
al. 1992; Wu et al. 2007). Nisin has successfully been used to control respiratory tract 
infection by S. aureus in animal model (De Kwaadsteniet et al. 2009) as well as in 
pharmaceutical applications as tooth paste and skin care products (Arauz et al. 2009).
Six natural nisin variants have been identified and characterized to date: nisin A 
(Kaletta and Entian 1989), nisin Z (Graeffe et al. 1990, Kuipers et al. 1990; Rauch et al. 
1990), nisin Q (Zendo et al. 2003), and nisin F (De Kwaadsteniet et al. 2008) are produced 
by L. lactis species while nisin U and nisin U2 are produced by S. uberis (Wirawan et al. 
2006) as illustrated in Figure 1. 
 Nisin killing activity involves the formation of voltage-dependent pores in the cell 
membrane (Hechard and Sahl 2002; Wiedemann et al. 2004), the prevention of murein 
synthesis (Reisinger et al. 1980), and the induction of autolysis of susceptible cells 
(Bierbaum and Sahl 1985). 
Autolysis of cells is a consequence of the release of two cell wall-hydrolyzing enzymes, 
N-acetylmuramoyl-l-alanine amidase and N-acetylglucosaminidase (Bierbaum and Sahl 
1987). Nisin has also been shown to reduce thermal resistance of Bacillus spores (Beard et 
al. 1999) and to prevent the germination of Bacillus (Nissen et al. 2001) and Clostridium 
Figure 1. Variants of the nisin bacteriocin. Black circles indicate amino acid differences compared to 
nisin A. Post-translational modifi cations are indicated in grey. Adapted from Field et al. 2008.
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6(Thomas et al. 2002) spores. Mutational analyses have shown that the rings situated in the 
N-terminal domain (rings A, B and C) are involved in lipid II binding, whereas mutations 
in the fl exible middle part (Asn20–Met21–Lys22) of the peptide affect the ability of nisin 
to form pores in the membrane of the target cell (Breukink et al. 1999; Wiedemann et al. 
2001) and the dehydroalanine residue at position 5 effects the inhibition of the outgrowth 
of bacterial spores (Chan et al. 1996).The effect of nisin on germinating spores may depend 
not only on the presence of Dha5 but might be also dependent on pore formation in the cell 
membrane of the germinating spores (Rink et al. 2007).
2.1. Nisin biosynthesis 
The structural genes nisA/Z/Q encodes the 57-aa prepeptide containing a 23-aa N-terminal 
leader peptide (55-aa prepeptide and 24-aa leader in nisin U, and 34-aa prepeptide and 
13-aa leader in nisin F ) (Buchman et al.1988; Kaletta and Entian 1989; Dodd et al. 1990; 
Steen et al.  1991; Graeffe et al. 1991; Mulders et al. 1991; Zendo et al. 2003; Wirawan et 
al. 2006; de Kwaadsteniet et al. 2008).
Prenisin is subjected to various post-translational modifi cations including dehydration, 
lanthionine ring formation, secretion, and cleavage of the leader peptide to become 
biologically active. The production of active nisin in L. lactis requires a total of 14 kb 
of DNA in a conjugative nisin-sucrose transposon carrying eleven nis genes, nisA/Z/
QBTCIPRKFEG (Fig. 2) (McAuliffe et al. 2001; Zendo et al. 2003). The nsu genes in S. 
uberis nisin U locus are closely similar to the lactococcal nis genes, but they are arranged in 
different order, nsuPRKFEGABTCI (Wirawan et al. 2006).
Biosynthesis of nisin is encoded by gene clusters containing conserved genes that are 
involved in production, maturation, immunity, and regulation (Engelke et al. 1994; Kuipers 
et al.  1995; Qiao 1996; Qiao et al.1996; Siezen et al. 1996; Kleerebezem and Quadri 2001), 
which are located on a large conjugative nisin-sucrose transposon (~70 kb), Tn5276. 
The nisin regulon includes the genes responsible for intracellular post-translational 
modifi cations, the dehydration reactions and ring formation (NisBC) (Engelke et al. 1992; 
Kuipers et al. 1993; Koponen et al. 2002), transport across the cytoplasmic membrane 
(NisT) and cleavage of the leader peptide (NisP) (van der Meer et al. 1993; Qiao and Saris 
Figure 2. Scheme of the nisin A/Z/Q regulon adapted from Takala and Saris 2007. Promoters marked 
in (fi lled triangle) are controlled by a two-component system NisRK. Transcription of nisRK and nisI 
is mainly from the nisA/Z promoter but in non-nisin production conditions expression is weak and 
constitutive (open triangles). Hairpins indicate transcription terminator loops or for stabilization of 
the mRNA end. 
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71996), which liberates biologically active nisin.  The biosynthesis of nisin is autoregulated 
by the two-component regulatory system NisRK (Engelke et al. 1994; Kuipers et al. 1995; 
Qiao et al. 1996; Kleerebezem and Quadri 2001; Kleerebezem 2004). Nisin immunity is 
encoded by four genes in the nisin operons. Three of the immunity proteins, NisF, NisE, 
and NisG, form an ABC transport complex (Siegers and Entian 1995; Immonen and 
Saris 1998). NisF is a cytoplasmic ATP-binding protein. NisE and NisG are hydrophobic 
integral membrane proteins. The function of NisFEG complex is to export cell-associated 
nisin to the external environment (Stein et al. 2003). NisI is a lipoprotein attached to the 
extracellular side of the cell membrane encoded by the nisI gene and protects the cell 
against nisin (Kuipers et al. 1993; Qiao et al. 1995). However, the actual mechanism of 
NisI-mediated immunity is not fully clear. NisI could function as an interceptive protein 
lowering the quantity of nisin molecules on the membrane. It has also been suggested 
that NisI may prevent nisin from reaching the membrane, hinder nisin insertion into the 
membrane (Saris et al. 1996), or it may act as a binding protein delivering nisin to NisFEG 
transporter (Immonen and Saris 1998). Takala et al. (2004) showed a new mechanism of 
nisin immunity mediated by secretion of lipid-free NisI. In this study the signal sequence 
of NisI was replaced with a non-lipoprotein signal sequence. Consequently, all NisI 
produced was secreted into the medium. This NisI secretion resulted in a low level of nisin 
immunity. External addition of lipid-free NisI to cells did not protect cells from the lethal 
action of nisin. On the contrary, external addition of lipid-free NisI enhanced the activity 
of nisin (Koponen et al. 2004). Therefore, protection by lipid-free NisI seemed to require a 
constant fl ow of NisI for clearing the membrane from nisin. During the transport from the 
membrane to the growth medium lipid-free NisI could potentially interact with NisFEG 
as the protection mediated by secretion of lipid-free NisI was much higher in a NisFEG 
expressing background (Takala et al. 2004).
2.2. Regulation of nisin
Survival of LAB in different niches is in partly due to their ability to sense other members 
and signals within their environment, which facilitates the coordination of nutrient 
acquisition, and awareness to the presence of other competitors. Therefore, LAB have 
evolved different communication methods to sense the environment around them and to 
initiate an appropriate transcriptional response (O’Flaherty and Klaenhammer 2009). 
Several lantibiotics are produced in a growth-phase-dependent (or cell-density-dependent) 
manner and their biosynthesis is under the control of bacterial two-component regulatory 
system (TCS). Typically, it consists of a histidine protein kinase (HPK), usually a membrane 
protein capable of sensing a specifi c environmental signal, and a cytoplasmic response 
regulator (RR), which translates the incoming signal into a cellular adaptive response (Klein 
et al. 1993; Engelke et al. 1994; Kuipers et al. 1995; Qiao et al. 1996; Ra et al. 1996; Altena 
et al. 2000; Kleerebezem and Quadri 2001; McAuliffe et al. 2001). Genes encoding both 
response regulators and sensor histidine kinases have been identifi ed in the gene clusters 
of nisin (nisR and nisK, Engelke et al. 1994), subtilin (spaR and spaK, Klein et al. 1993), 
salivaricin (salR and salK, Ross et al. 1993).
 As shown in Figure 3,  the sensor kinase NisK autophosphorylates a conserved 
histidine residue in the C-terminal cytoplasmic transmitter domain of the protein in 
response to the external signal by fully modifi ed nisin. The phosphoryl group is transferred 
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transcriptional activator (McAuliffe et al. 2001) that activate the induction of the nisA 
and nisF promoters of nisABTCPIRK and nisFEG inducing transcription of genes that are 
required for nisin biosynthesis and immunity within the nisin gene cluster via the two-
component signal transduction machinery composed of NisK and NisR (Kuipers et al. 
1995; Ra et al. 1996; Kleerebezem et al. 1999; Kleerebezem and Quadri 2001). 
Figure 3. Scheme of nisin biosynthesis and regulation in Lactococcus lactis (adapted from Chatterjee 
et al. 2005).
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2.3. Nisin secretion; transport and proteolytic processing
Deletion or disruption of nisT abolishes the secretion of nisin, and leads to accumulation of 
nisin in the cytoplasm (Qiao and Saris 1996). Secretion of nisin can be restored by providing 
the nisT gene on a plasmid (Qiao and Saris 1996). These results strongly suggested that 
the modifi ed nisin precursor is secreted from the cell by the ABC-type transporter NisT 
(Qiao and Saris 1996). Finally, the leader sequence is removed by the protease NisP and 
biologically active nisin is released (van der Meer et al. 1993). 
There are two separate ABC transporters associated with nisin production/immunity, 
one exporting the prenisin and another involved in immunity. The prenisin exporter 
(NisT) fall into class 1 (Dassa and Bouige (2001), which comprises the majority of known 
exporters with fused ABC and integral membrane domains (IM). Class 2 ABC transporters 
are often involved in cellular processes other than transport. Protein transporters associated 
9with nisin immunity are found in class 3. ABC exporters commonly share two main regions 
of homology, i.e. membrane-spanning domains in the N-terminal half, and an ATP-binding 
motif in the C-terminal, where ATP hydrolysis is the source of energy for secretion (Fath 
and Kolter 1993). Siegers et al. (1996) suggested that at least two NisT molecules form a 
dimer and showed an interaction between the carboxyl terminal domain of NisT and NisC 
with yeast two-hybrid system.  
As shown in Figure 4, post-translational processing of nisin occurs most likely at the 
cytoplasmic membrane. Ribosomally synthesized nisin is fi rst dehydrated by NisB (step 1 
to 2), then cyclized by NisC (step 2 to 3) and transported across the lipid bilayer by NisT 
(step 3 to 4). Subsequently, the nisin leader sequence is cleaved off by the protease NisP (4).
NisT transporter have shown by Kuipers et al. (2004) to have a broad substrate 
specifi city, transporting the unmodifi ed prenisin, dehydrated prenisin, and  non-lantibiotic 
peptides, which may enable the synthesis and export of a wide variety of peptides. 
The presence of the leader sequence attached to the fully modifi ed nisin keeps the 
peptide in an inactive state. NisP is a serine protease with an amino terminal secretory 
signal sequence (N-terminal sec-signal sequence), a potential signal peptidase cleavage 
site (predicted to be between Gly-22 and Glu-23), a catalytic site, and a C-terminal cell 
wall anchor, the LPXTG sequence involved in anchoring surface proteins of Gram-positive 
bacteria (Siezen, 1999). Kuipers et al. (2004) have shown that neither unmodifi ed nor 
Figure 4. Post-translational processing of prenisin. A) Processing takes place at the cytoplasmic 
membrane (adapted from Siegers et al. 1996). B) Post-translational modifi cation steps (adapted from 
Kuipers et al. 2004).
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dehydrated prenisin can be cleaved by NisP and its activity is not coupled to the transport 
step by NisT. NisP is assumed to be a protease with rather narrow substrate specifi city (van 
der Meer et al. 1993; Qiao et al. 1996).
2.4. Detection and quantifi cation of nisin
The maximum levels of nisin as a food additive in foods have been set in various countries 
(Cleveland et al. 2001). Therefore, several methods for nisin detection and quantifi cation 
have been developed. 
The most commonly used analytical tools for the determination of nisin concentration 
are biological assays (agar diffusion tests) (Tramer and Fowler 1964; Wolf and Gibbons 
1996), but the drawbacks of these methods include lack of specifi city and limited sensitivity.
Immunochemistry-based methods (Suárez et al. 1996; Bouksaim et al. 1998) are 
gaining attention (Bernbom et al. 2006), although cross-reactivity with lantibiotic subtilin 
(Falahee and Adams 1992) or other variants of nisin, such as nisin Z (Suárez et al. 1996) 
can occur with such methods. 
Nisin bioassays based on inducible bioluminescence (Wahlström and Saris 1999; 
Immonen and Karp 2007), or fl uorescence (Reunanen and Saris 2003; Hakovirta et al. 2006) 
are the most sensitive achieving detection limits in the range of picograms per millilitre.
Presently, the most sensitive nisin detection system is the improved luciferase assay 
introduced by Immonen and Karp (2007). In this assay, the complete set of luciferase genes 
from Photorhabdus luminescens, luxABCDE, are under the control of the nisA promoter. 
The detection limit for nisin quantifi cation was reduced to 0.1 pg nisin ml-1 in pure solution 
and 3 pg nisin ml-1 in milk.
The sensitivity of the nisin GFPuv bioassay allows extensive dilution of foods, thus 
minimizing materials which could interfere with the analysis, and has been shown to be 
compatible with different food matrices (Hakovirta et al. 2006).
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3.  FLOW CYTOMETRY (FCM) AND FLUORESENCE-ACTIVATED
 CELL SORTING (FACS) OF BACTERIAL CELLS
FCM is a standard method for making rapid measurements on each cell within a suspension. 
As the cells in a fl uid stream fl ow individually through a sensing point, manifold cellular 
properties can then be measured from fl uorescence and light scatter (Shapiro 1995; Davey 
and Winson 2003).
In the late 1970’s improvements in optics technology and the development in 
staining techniques and reporter gene technology have increased the usability of FCM in 
microbiological research (Steen 2000; Longobardi and Givan 2001; Müller-Taubenberger 
and Anderson 2007).
 FCM-based applications have been utilized for analysis of the bacterial cell cycle, 
detection of clones and mutants by reporter genes, such as lux and gfp, assessment of 
antibiotic susceptibility, to the determination of expression of intracellular or cell surface 
antigens (Link et al. 2007). 
A typical fl ow cytometer (Fig. 5A) composes of four major units: a light source, fl uidics 
system, optics, and signal processing (Longobardi and Givan 2001).Sample suspension is 
injected into the centre of an enclosed channel through which liquid is fl owing in the center 
of the sheath fl uid (a cell-free fl uid) surrounding the centre sample stream holding cells 
aligned in single fi le.
Figure 5. Schematic presentation of fl ow cytometer and fl uorescence-activated cell sorter (FACS). 
A) Flow cytometery setup. B) A cell passing through the laser beam is monitored for fl uorescence. 
Droplets containing single cells are given a negative or positive charge, depending on whether the 
cell is fl uorescent or not. The droplets are then defl ected by an electric fi eld into collection tubes ac-
cording to their charge. Adapted from Alberts et al. 2002.
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Particles/cells passing through the laser beam will scatter light, which is detected as 
forward scatter (FS) and side scatter (SS). Forward scatter refl ects the particle’s size and 
side scatter is roughly proportional to the granularity of a particle (Davey and Kell 1996). 
Forward and side scattered light and fl uorescence from stained cells are split into 
defi ned wavelengths and channeled by a set of fi lters and mirrors within the fl ow cytometer. 
The fl uorescent light is fi ltered so each sensor will detect fl uorescence only at a specifi ed 
wavelength. These sensors are called photomultiplying tubes (PMT’s), and they convert the 
energy of a photon into an electronic signal (voltage). Each pulse for each cell is known 
as an event. The measured voltage pulse area will correlate directly to the intensity of 
fl uorescence for that event.  In this manner cell populations can often be distinguished 
based on differences in their size and density.
In the mid 1960s the demand to analyze a cell of interest led to the inclusion of cell 
sorting feature in the fl ow cytometers (Fulwyler 1965; Kamentsky and Melamed 1967). 
Cell sorting has greatly extended the research and diagnostic potential of the 
fl ow cytometer and such important extension is particularly relevant to microbiology 
(Kaprelyants et al. 1996; Wallner et al. 1997; Robinson 2004). 
Cell sorting is the process of physically separating particles or cells of interest from 
the mixed population. Cell sorters have the ability to electronically defl ect cells (sort) with 
defi ned properties between two high voltage plates, and collected into separate collection 
tubes as it shown in Figure 5B. When appropriate cell staining and sample preparation 
methods are used to maintain viability, sorted cells can be grown to give clonal colonies 
or broth suspensions, which has particular advantages in molecular biology for isolating 
mutants (Bell et al. 1998).
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4.  CHICKEN MICROBIOTA AND THE POTENTIAL OF LAB 
 AND/OR THEIR ANTIMICROBIAL PEPTIDES IN CHICKEN 
FARMING
Lactic acid bacteria (LAB) are important components of the healthy intestinal microbiota of 
chicken. The LAB population levels in the chicken digestive tract are higher than 107 viable 
cell g-1 (Fuller 1977). The dominance of LAB species can vary depending on anatomical 
site (Zhu and Joerger 2003). Collado and Yolanda (2007) analyzed GIT of chickens by 
fl uorescence in situ hybridization combined with fl ow cytometry (FCM-FISH) and showed 
that LAB were one of the predominant mucosa-associated bacteria in broilers. They account 
for 20 % of the total crop microbiota, 29 % of the small intestine, and 23 % of the large 
intestine.
During the fi rst week of life, the genus Lactobacilli and Enterococci are the dominant 
species in the crop, duodenum, and ileum (Knarreborg et al. 2002; Guan et al. 2003).
Whereas Lactobacilli, coliforms, and Enterococci are present in high numbers in the 
caecum (Mead and Adams 1975; van der Wielen et al. 2000; Snel et al. 2002; Zhu et al. 
2002). After the fi rst week, Lactobacilli dominate the crop, duodenum, and ileum, while a 
group of obligate anaerobes begins to dominate the caecum. After 2 to 3 weeks, a stable 
intestinal microbiota is established (Snel et al. 2002). Zhu and Joerger (2003) indicated that 
some 240 species are recognized residents of the GIT of broiler chicken using 16S rRNA-
based analysis. 
The GIT of chickens may offer a potential source for: (i) isolation of probiotic LAB 
strains suitable for use as feed supplements for poultry or other animals (ii) and AMPs 
that reduce the colonization of pathogen-infected chickens which represent a source for 
human infections. Lactic acid bacteria probiotics and competitive exclusion preparations 
have been studied for application in poultry production and some are currently in use 
(Nurmi and Rantala 1973; Morishita et al. 1997; Pascual et al. 1999). Additionally, LAB 
antimicrobial peptides are believed to be important in the ability of LAB to compete in non-
fermentative ecosystems such as the gastro-intestinal tract (Dyke et al. 1995). On the other 
hand, intestinal pathogens have to overcome a multifaceted defense system consisting of 
low gastric pH, rapid transit through sections of the intestinal tract, as well as the intestinal 
microbiota, epithelium, and immune systems. 
LAB and/or their AMPs are essential to a functional gastrointestinal tract and 
immune system in animals. They serve many functional roles for the animal, including 
the degradation of ingesta, pathogen exclusion, the production of short-chain fatty acids, 
detoxifi cation of harmful components (Salminen 1990), vitamin supplementation, and 
immune development (Nurmi and Rantala 1973; Stevens and Hume 1998; Hooper et al. 
2003). 
4.1 The alternatives to growth-promoting antibiotics (GPA) in poultry production
In the poultry industry, antibiotics are used to prevent poultry pathogens and disease as 
well as to improve meat and egg production. An improvement in poultry growth due 
to antibiotic usage was fi rst described in the mid 1940s and since then the addition of 
GPA became a common practice (Moore et al. 1946). Bedford (2000) pointed out that 
the growth-promoting effects of antibiotics in animal diets are clearly related to the gut 
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microbiota because they exert no benefi ts on the performance of germ-free (GF) animals. 
The extensive use of antibiotics in animal farms has led to an imbalance of the benefi cial 
intestinal microbiota and accumulation of antibiotic resistance factors (Bedford 2000).
 Furthermore, bacteria resistant to antibiotics may also enter the food chain and transfer 
the antibiotic resistance factors to the microbiota of humans (Patterson and Burkholder 
2003).
The emergence of antibiotic resistant pathogens from animals fed with antibiotics has 
led the European Union to pass legislation that prohibits the subtherapeutic application 
of antibiotics in animal agriculture (Casewell et al. 2003). Anticoccidial substances, such 
as antibiotics ionophores, will be prohibited as feed additives before 2013. After this 
date, medical substances in animal feeds will be limited to therapeutic use by veterinary 
prescription.
Moreover, the consumer demand for minimally processed or natural food has led to 
reduction in antibiotic usage in animal feed. Therefore, an intensive pressure is placed on 
natural alternatives for enhancing animal productivity and improving product safety.
 Cervantes (2005) reviewed the impact of the antibiotic ban in the EU based on 
the Danish integrated anti-microbial resistance monitoring and research programme 
(DANMAP, 2004) and how it has resulted in a signifi cant decrease of antibiotic resistance 
among bacteria isolated from raw meat products. Therefore, the major focus of alternative 
strategies has been to prevent the proliferation of pathogenic bacteria and the modulation 
of indigenous bacteria so that the health, immune status and performance of chickens are 
improved (Ravindran, 2006).
The use of LAB and/or their AMPs has been proposed for poultry to contribute in 
maintaining the integrity of the animal and the humans consuming the animals. Specifi c 
probiotic LAB are fed to animals to improve animal performance, and CE product bacteria 
are fed to eliminate animal pathogen colonization. They seem logical alternatives to growth 
promoter antibiotics (Patterson and Burkholder 2003).
4.1.1 Competitive enhancement techniques 
Strategies have been devised to reduce the populations of food-borne pathogenic bacteria 
in poultry on the farm level, which rely on the natural competitive nature of bacteria to 
eliminate pathogens that negatively impact animal production or food safety. 
Feed products that are classifi ed as probiotics, prebiotics and competitive exclusion 
cultures have been utilized as strategies for reducing pathogens in animals. The effi cacy of 
such products is often due to specifi c microbial ecological factors that alter the competitive 
pressures experienced by the microbial population in the gut. Competitive enhancement 
techniques include: (1) introduction of a normal microbial population to the gastrointestinal 
tract (CE products), (2) addition of a microbial supplement called a probiotic that improves 
gastrointestinal health (Collins and Gibson 1999), (3) providing a specific nutrient 
‘prebiotic’ that allows commensal microbial species to expand its current niche or to occupy 
a new niche in the gastrointestinal tract and (4) the use of peptide bacteriocins.
4.1.1.1 Competitive exclusion (CE)
The normal intestinal microbiota protects the host against invading pathogens and this 
phenomenon has been described in the literature as ‘bacterial antagonism’, ‘bacterial 
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interference’, ‘competitive exclusion’ (Nurmi and Rantala 1973; Fuller 1973; 1989) or the 
“Nurmi concept” according to the father of this invention in poultry (Pivnick and Nurmi 
1982). Rantala and Nurmi (1973) attempted to control a severe outbreak of S. infantis in 
Finnish broiler fl ocks. In their studies, it was determined that very low challenge doses of 
Salmonella (1 to 10 cells into the crop) were suffi cient to initiate salmonellosis in chickens 
during the fi rst week post-hatch. Use of a Lactobacillus strain did not give protection, and 
this forced them to evaluate an unmanipulated population of intestinal bacteria from adult 
chickens that were resistant to the S. infantis. On oral administration of this undefi ned 
mixed culture, adult-type resistance to Salmonella was achieved. Later, this procedure 
became known as the Nurmi or competitive exclusion (CE) concept.
CE technology involves the addition of a nonpathogenic bacterial culture of a single 
or multiple strains in order to reduce colonization populations of pathogenic bacteria in the 
gastrointestinal tract (Fuller 1989; Nurmi et al. 1992; Nisbet et al. 1993; Steer et al. 2000). 
Lactobacillus and Bifi dobacterium species have been used most extensively in humans, 
whereas species of Bacillus, Enterococcus, and Saccharomyces yeast have been the most 
common organisms used in livestock (Salminen et al. 1998).
Although competitive exclusion fits the definition of probiotics, the competitive 
exclusion approach provides the chickens on the day-of-hatch with an adult intestinal 
microbiota instead of adding one or a few bacterial species to an established microbial 
population. 
In the poultry industry, chickens can be quickly colonized by pathogens after 
hatching (Cox et al. 1990) due to delayed development of their intestinal fl ora. Therefore, 
an introduction of a mixed microbial product to the gut of a neonate can aid in the early 
establishment of a normal microbial population and prevent the establishment of a 
pathogenic bacterial population (Crittenden 1999; Steer et al. 2000). 
Most CE research has focused on poultry (Nava et al. 2005) which can be attributed 
to the need to control Salmonella colonization and other bacterial diseases in poultry. 
Commercial CE products comprised of several defi ned species of bacteria are available 
such as Aviguard (Life-Care Products Ltd, UK), MSC (Stern et al. 1995), Preempt (Corrier 
et al. 1995) and Broilact® (Orion Corporation, Finland). Broilact® is a selected mixture of 
22 strictly anaerobic rods and cocci and 10 different facultatively anaerobic rods and cocci 
derived from the caecum of a healthy adult hen. Broilact® has been used to protect chickens 
from intestinal colonization and invasion of the heart, liver and spleen by S. enteritidis and 
S. typhimurium (Schneitz et al. 1990; Bolder et al. 1992; Cameron and Carter 1992; Nuotio 
et al. 1992; Methner et al. 1997; Schneitz and Hakkinen 1998). In addition, it decreased 
Campylobacter jejuni numbers in the cecal contents (Bolder et al. 1995; Hakkinen and 
Schneitz 1999), and it provided good protection against E. coli and E. coli O157:H7 
(Hakkinen and Schneitz 1996).
A Lactobacillus reuteri culture (Talarico et al. 1988) is also marketed for use against 
enteropathogens, but seems to be rather ineffective (Edens et al. 1994; 1997). In poultry 
farming, CE treatment is normally given to newly hatched chickens or turkeys soon after 
hatching, either by spraying (Schneitz et al. 1990) in the hatchery or on the farm or in the 
fi rst drinking water (Schneitz et al. 1990; Martin et al. 2000). CE cultures are considered a 
viable technique for poultry due to their short production cycle explaining their wide use 
(Weinack et al. 1982; Fuller 1989; Nurmi et al. 1992; Stavric 1992; Stavric and D’Aoust, 
1993; Bielke et al. 2003).
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The intestinal bacteria including pathogens are believed to grow as fast as the passage 
rate of their environment, if not the constant fl ow of digesta would ‘wash out’ the pathogen. 
When a CE preparation or the natural fl ora is established within the gut, bacteria bind to 
the surface of the intestinal epithelium preventing opportunistic pathogens from attaching 
(Fuller 1989; Nurmi et al. 1992; Collins and Gibson 1999; Steer et al. 2000). Additionally, 
some bacteria produce antimicrobial protein compounds, such as traditional antibiotics and 
bacteriocins or colicins that can inhibit or eliminate species competing within the same 
niche (Nurmi et al. 1992; Crittenden 1999; Steer et al. 2000, Stahl et al. 2004; Al-Qumber 
and Tagg 2006). Moreover, a synergistic interaction of two or more of the above mentioned 
activities may infl uence the effectiveness of a CE preparation.
CE preparations showed limited success in preventing colonization by Campylobacter 
spp. in chicken ceacum (Stern et al. 1992). Stern et al. (1992; 1994) reported that CE 
preparations, effective against Salmonella, are not consistently effective against chicken 
colonization by C. jejuni. It is known that C. jejuni occupies another intestinal niche than 
Salmonella, primarily moving freely in the mucus layer of the caecal crypts (Beery et al. 
1988). This suggests that different composition of the protective bacteria may be needed to 
improve the result of CE. However, protection against Campylobacter has also been shown 
by using two of the CE products (Hakkinen and Schneitz 1999; Stern et al. 2001). With 
pig mucus Collado et al. (2007) showed that the combination of the probiotic cultures L. 
rhamnosus LGG and B. lactis Bb12 increased the percentages of adhesion of both strains 
and also inhibited the adhesion of pathogens signifi cantly better than inhibition achieved 
usingby monocultures. This result urge for more research of which combination of strains 
would be favorable for development of effective CE preparations.
In Finland, the broiler industry is relatively small and the climate is colder than in 
many other countries, which may aid in the control of Salmonella and Campylobacter by 
CE treatment and other means. Potentially, CE cultures are expected to be a green method 
to reduce Salmonella in eggs and in broilers shipped into the EU.
4.1.1.2 Probiotics
Benefi cial bacteria applied to animal feed stuffs are commonly referred to as probiotics. The 
term probiotic means “for life” in Greek (Gibson and Fuller 2000), and has been defi ned as 
“a live microbial feed supplement which benefi cially affects the host animal by improving 
its intestinal balance” (Fuller 1989). LAB are used as probiotics for human and animals 
(Donohue and Salminen 1996; Salminen et al. 1998).
 A potentially LAB probiotic strain is expected to have several desirable properties to 
exert within its host. They should be able to overcome the low pH of gastric juice and the 
bile salts effect and arrive at the site of action in a viable physiological state (Salminen et al. 
1989; 1999), and to adhere and colonize the mucosal surfaces to prevent pathogens through 
competition for binding site and nutrients (Ouwehand 1998; Ouwehand et al. 1999; Naidu 
et al. 1999). 
The list of microorganisms used in animal feed in the European Union (EU) includes 
mainly strains of Gram-positive bacteria belonging to Bacillus (B. cereus var. toyoi, B. 
licheniformis, B. subtilis), Enterococcus (E. faecium), Lactobacillus (L. acidophilus, 
L. casei, L. farciminis, L. plantarum, L. rhamnosus), Pediococcus (P. acidilactici), 
Streptococcus (S. infantarius), and some yeasts like Saccharomyces cerevisiae and 
Kluyveromyces (Arturo et al.  2006). There are many reports indicating the effectiveness of 
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LAB probiotic products as an alternative to antibiotic use in broiler production. L. salivarius 
has potential for use as a probiotic for chickens. Garriga et al. (1998) isolated eight different 
L. salivarius strains with high effi ciency of adherence to the epithelial cells of chickens and 
they were able to inhibit enteric pathogens Salmonella enteritidis and Escherichia coli. The 
effi cacy of probiotics may be enhanced through the selection of more effi cient strains, gene 
manipulation, the combination of several strains, and by combining them with prebiotics 
(probiotic + prebiotic = symbiotics). 
Typically, probiotic preparations for use in animals are comprised of single species 
or mixtures of lactic acid bacteria (LAB), yeasts, or their end products (Wiemann 2003). 
Probiotics comprised of Bifi dobacterium lactis and Lactobacillus rhamnosus individually 
reduced adherence of Salmonella, E. coli and Clostridum spp. to the intestinal mucosa in 
swine. Together the two organisms were more effective but reduced each other’s adherence 
(Collado et al. 2007).
In poultry, the development of the immunological function of gut-associated lymphoid 
tissue (GALT) is critical for survival immediately after hatching. Clancy (2003) proposed 
the concept of immunobiotics for microorganisms that stimulate activation of mucosal 
immunity in the GALT (Clancy 2003). Stimulation of immune responses by probiotic 
cultures has been described in several animal models. The use of probiotic products have 
been shown to affect immune parameters and increase CD8 production, as well as IgG and 
IgM concentrations in the serum and gut of swine (Duncker et al. 2006, Walsh et al. 2008). 
A recent study by Sato et al. (2009) investigated in vitro-selected immunobiotic lactic 
acid bacteria effect on the development of GALT immune function in posthatch chicks. 
Immunobiotic lactic acid bacteria (i.e., L. jensenii TL2937 and L. gasseri TL2919 in 
particular) are appropriate immunomodulators to stimulate the gut-associated immune 
system in chicks. These selected immunobiotic LAB might therefore be useful supplements 
for improving the immune system without decreasing growth performance in neonatal 
chicks. 
4.1.1.3 Prebiotics
Numerous defi nitions of prebiotics with subtle variations have been given in the past 
decades (Gibson and Roberfroid 1995; Gibson 1998; Patterson and Burkholder 2003; 
Lan 2004). According to FAO (2007) the defi nition of a prebiotic is”a non-viable food 
component that confers a health benefi t on the host associated with modulation of the 
microbiota”.  The application of prebiotics in chicken diets does not have as long a history 
as in human or pet’s food. The prebiotics effects on the activity of the chicken microfl ora 
are limited and variable based upon the type of prebiotic (Yang et al. 2009). 
It has been shown that dietary supplementation of prebiotics has stimulated 
the unculturable important commensal bacteria in humans (Rastall et al. 2005) and 
animals (Snel et al. 2002). Most current successes have been derived by non-digestible 
oligosaccharides, especially those containing fructose, xylose, galactose, glucose and 
mannose (Gibson and Roberfroid 1995; Gibson 1998). Prebiotics have been studied in 
humans and animals to improve resistance to pathogens. Buddington et al. (2002) has 
shown that dietary supplementation of fructooligosaccharides and inulin was protective 
against enteric pathogens (E. coli O157:H7 and Campylobacter) and tumor inducers in 
mice. 
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The impact of such selective-fermentation prebiotics is that they increase lactic acid 
producing bacteria and short-chain fatty acid (SCFA) in the caecum leading to decreased 
GIT pH, which inhibit susceptible Gram-negative organisms. The rise in intestinal lactic 
acid bacteria stimulated phagocytic activity (cellular immune response) and/or IgA 
secretion (humoral immune response) and may affect the colonization of pathogens, such 
as Salmonella and rotavirus (Manning and Gibson 2004). Many studies have reported that 
combining a number of probiotics (Jin et al. 1998; Line et al. 1998; Fritts et al. 2000) and 
prebiotics (Chambers et al. 1997; Fukata et al. 1999) may result in reduced colonization and 
shedding of Salmonella and Campylobacter. Such a combination could improve the survival 
of the probiotic organism due to the availability of its specifi c substrate for fermentation. 
Hence, the dietary supplementation of prebiotics is a good approach that may reduce enteric 
disease or colonization of zoonotic pathogens in poultry and subsequent contamination of 
poultry products (Patterson and Burkholder 2003). 
4.2 Campylobacter and chicken farming
Food-borne illnesses are a major public health concern. C. jejuni and C. coli are food-
borne pathogens of humans causing enteritis and neurologic disease. The association of 
Campylobacter infections with chronic and potentially life-threatening autoimmune 
conditions such as Guillain-Barre´syndrome (Rees et al. 1993) have served to heighten 
concern over this organism since its isolation from human stools in the 1970s (Sanders 
et al. 2002). Campylobacteriosis in humans is characterized by watery or bloody 
diarrhea, abdominal cramps and nausea (Skirrow and Blaser 2000). Only a few species 
of Campylobacter result in clinical disease in animals, including C. fetus ssp. fetus and 
Campylobacter fetus ssp. venerealis, which cause reproductive diseases (Sanders et al. 
2002). Other species of Campylobacter, including those causing enteritis in humans, do 
not result in clinical disease in animals. Frequently, the poultry fl ocks are colonized with 
C. jejuni without apparent symptoms (Shane 2000) and risk assessment analyses have 
identifi ed handling and consumption of poultry meat as one of the most important sources 
of human campylobacteriosis (Potter et al. 2003; Friedman et al. 2004). Several studies 
have demonstrated that horizontal transmission is the major route of Campylobacter 
colonization of poultry as the same strain has been shown to colonize multiple fl ocks on 
a farm (Sahin et al. 2002; Newell and Fearnley 2003). However, some investigations have 
detected egg-associated bacteria, suggesting that vertical transmission could occur (Neill 
et al. 1985; Allen and Griffi ths 2001; Cox et al. 2002). Campylobacter´s colonization 
sites are the caecum, small intestine, large intestine, and cloaca. Although it is generally 
accepted that campylobacters have evolved to rapidly and effi ciently colonize the avian 
gut (Beery et al. 1988), poor colonizers have been also identifi ed (Korolik et al. 1988). 
Mutations in certain genes associated with motility, capsule formation, chemotaxis, and 
microaerobic respiration, result in a reduced ability to colonize chickens (Jones et al. 2004). 
Several studies reported that 80% of broiler chickens that are between 5 and 7 weeks old 
can carry C. jejuni or C. coli in the intestinal tract (Sahin et al. 2002; Newell and Fearnley 
2003). Crops of market age broilers often contain Campylobacter (Berrang et al. 2000), 
and crop contents are a source of carcass contamination with campylobacteria (Byrd et al. 
1999; Berrang et al. 2000). Campylobacter are commensal organisms in chickens, and are 
a common contaminant of raw poultry products (Korolik et al. 1989; Farerell and Harris 
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1991; Speed et al. 1999). Raw poultry meat is considered to be an important vector of 
Campylobacter (Samuel et al. 2004). Campylobacter -infected chickens represent the main 
source of human campylobacteriosis and 90% of the cases are caused by C. jejuni and only 
10% by C. coli.
It is generally accepted that Campylobacter –contaminated broilers is a signifi cant risk 
factor of human campylobacteriosis and hence the control of C. jejuni in poultry would 
reduce the risk of human exposure to Campylobacter. Elimination of Campylobacter in the 
poultry reservoir is a crucial step to control this food safety problem. The greatest impact 
to control campylobacteria would be a farm-based strategy as it represents an amplifi cation 
point for campylobacteria throughout the food chain (Newell and Wagenaar 2002; Wagenaar 
et al. 2008).
Several farm-based interventions have been proposed to control campylobacteria 
in poultry which can be summarized as three strategies: 1) reduction of environmental 
exposure (2) an increase in poultry’s host resistance to reduce Campylobacter in the GIT 
of poultry e. g., competitive exclusion and vaccination, and (3) the use of antimicrobial 
alternatives to reduce Campylobacter from colonized chickens e. g., bacteriophage therapy 
and bacteriocin treatment. Currently strategies 1 and 2 are still under development. At 
present, there is an urgent need for control measures that can be used in the fi eld and that 
are acceptable to consumers.
4.2.1 Antimicrobial peptides 
LAB represent the majority of  bacteriocin producing bacteria which are commensals 
in intestine (Cotter et al. 2005) and subsequently the intestinal bacteriocin–producing 
bacteria may function as an innate barrier against pathogens in the gut. Isolation of chicken 
commensal bacteria inhibitory to Campylobacter and characterization of their bacteriocins 
have been described (Svetoch et al. 2005; Stern et al. 2006; Line et al. 2008; Svetoch et al. 
2008). Such potent anti-Campylobacter bacteriocins are SRCAM 602 (Svetoch et al. 2005), 
OR-7 (Stern et al. 2006), E 50–52 (Line et al. 2008) and E-760 (Svetoch et al. 2008). 
Svetoch and colleagues reported the identifi cation and characterization of novel anti-
Campylobacter bacteriocin named SRCAM 602 produced by P. polymyxa NRRL B-30509. 
An evaluation study of the purifi ed bacteriocin was carried out (Stern et al. 2005). Oral 
administration of the purifi ed bacteriocin SRCAM 602 resulted in elimination of detectable 
Campylobacter colonization in the caecum.
Bacteriocin OR-7 from L. salivarius NRRL B-30514 is nearly identical to acidocin 
A produced by Lactobacillus acidophilus (Kanatani et al. 1995). This bacteriocin appears 
useful in reducing C. jejuni in poultry prior to processing since the OR-7 treatment 
reduced Campylobacter colonization more than million fold in chicken. Another two novel 
bacteriocins, E-760 and E 50–52 produced by E. durans and E. faecium, respectively, and 
isolated from broiler caecum (Line et al. 2008; Svetoch et al. 2008) has shown potential in 
reducing campylobacteria in chickens. Treatment with purifi ed  E-760 and E 50–52 resulted 
in more than 6.6 log reduction in10-day-old chickens with a dose as low as 31.2 mg/kg 
feed and > 6.4 log reduction in 15-day-old chickens with a dose as low as 31.2 mg/kg feed. 
Both bacteriocins displayed strong broad spectrum antibacterial activity against food-borne 
pathogens Salmonella spp., E. coli O157:H7, Listeria spp., and Shigella spp. as well as 
showing potent anti-Campylobacter activity. 
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Clearly, anti-Campylobacter bacteriocin treatment is an effective strategy to reduce C. 
jejuni load in chickens. 
4.2.2 Phage therapy
Bacteriophages have unique advantages over antibiotics in that they are both self-replicating 
and self-limiting. The lytic capability and host specificity of phages also present an 
opportunity for using them to reduce the numbers of campylobacteria from animal sources 
and subsequently reducing cross contamination during processing. 
Campylobacter-specific bacteriophages have been isolated from various sources; 
pig manure, abattoir, sewage, and broiler chickens (Grawjewski et al. 1985; Atterbury et 
al. 2003; Goode et al. 2003). However, Hudson et al. (2005) showed that the activity of 
bacteriophages is maximal at the optimal growth temperature of their host which is 40°C in 
Campylobacter.
 Phages have been used to treat animal diseases such as Salmonella (Sklar et al. 2001) 
and Escherichia coli (Huff et al. 2003). Group II Campylobacter phage, CP220 (El-Shibiny 
et al. 2009), with a genome size of 197 kb was administered as a single 7-log PFU dose 
to both C. jejuni- and C. coli-colonized birds resulting in 2-log CFU/g decline in cecal 
Campylobacter counts after 48 h. Wagenaar et al. (2005) reported a10-fold reduction in 
Campylobacter colonization compared with control chickens by using Campylobacter-
specifi c lytic phages. After an initial reduction, the camplylobacterial stabilized to levels 
of the untreated control chickens.  Phages are unlikely to be applicable for the reduction of 
enteric pathogens in the intestine of poultry on rearing farms, since fecal shedding of both 
pathogen and phages would rapidly lead to resistance. 
Phage therapy against campylobacteria in chickens is not yet commercially available. 
Using a phage to control Campylobacter may not meet with public acceptance unless 
it is successfully implicated and comprehensively presented (Atterbury et al. 2003). 
Communication with the public is essential, and public acceptance may be as diffi cult 
to obtain as with genetically modifi ed organism or their products. Leisner et al. (2005) 
described the obstacles for the introductionof pasteurization and starter cultures in the late 
19th century to indicate that the gap between industry, consumers and pressure groups is 
not an entirely new issue.
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5. AIMS OF THE STUDY 
The consumer demand for fresh, less processed food has increased the demand for natural 
food preservatives. Reducing the risk of human exposure to food-borne pathogens has a 
signifi cant impact on food safety and public health. Thus, the goal of this study was to 
characterize the functions of nisin in different ecosystems knowing that nisin is a natural 
food preservative and has a capacity to kill food-borne pathogens, and in addition to fi nd 
new bacteriocins for inhibition of campylobacteria. 
The detailed objectives are:
1. To study why the knockout of the NisT mutant caused induction of the nisZ promoter 
without addition of extracellular nisin.
2. To isolate natural mutants of the GFPuv nisin bioassay strain L. lactis LAC275 using 
fl uorescence-activated cell sorting FACS. 
3. To analyze the composition of the chicken crop microbiota and study the nisin resistance 
of the dominate crop species.
4. To isolate crop lactobacilli inhibiting Campylobacter jejuni and to characterize the 
inhibitory substance.
Aims of the study
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6. MATERIALS AND METHODS
6.1 Strains and plasmids
The bacterial strains used in this study are shown in Table 1, plasmids in Table 2 and primers 
in Table 3. The methods used in this study are indicated in Table 4, but are described in 
more detail in the Materials and Methods sections of the Publications I- IV. All strains used 
are deposited in the Saris laboratory culture collection (Helsinki, Finland) and some strains 
also in the HAMBI culture collection.  
Table 1. Strains used in this study
Strain Relevant properties Used 
in
Reference/source
Lactococcus lactis ssp. lactis  N8
L. lactis ssp. lactis NZ9800
L. lactis ssp. lactis NZ9000
L. lactis LAC46                     
L. lactis LAC53                     
L. lactis LAC104                   
L. lactis LAC67
L. lactis LAC85
L. lactis LAC109
L. lactis LAC108
L. lactis MG1614
L. lactisMG1614/pNZ9111
L. lactis LAC240
L. lactis LAC275 
L. lactis LAC344 
L. lactis LAC345 
Lactobacillus  reuteri 
HAN1-HAN19
L. reuteri HAN20-HAN41 
L. reuteri HAN42-HAN88
L. reuteri HAN89-HAN98
Lactobacillus reuteri CHCC1956
L. reuteri ATCC 55730 
L. crispatus HAN1-HAN56 
Lactobacillus salivarius LAB47 
L. salivarius LAB48-LAB86
L. salivarius NRRLB-30514               
Lactobacillus acidophilus/
johnsonii 
HAN156-HAN170                        
Lactobacillus sp. oral clone
Lactobacillus sp. strain CLE-4
L. gallinarum HAN171
L. helveticus HAN172
L. pentosus HAN173
Pediococcus acidilactici 
HAN174-180
Micrococcus  luteus 
A1NCIMB8166
Campylobacter jejuni SAA553-
560
Wild-type nisin producer
Non- nisin producer
nisRK genes
∆nisT 
∆nisB
∆nisC
∆nisZ
LAC46/pLEB384
LAC53/pLEB384 
LAC104/pLEB384
Host strain for constructed 
plasmids
Fully modifi ed prenisin
Indicator strain of GFP bioassay
Indicator strain of GFPuv bioassay
Natural mutant of LAC275
Natural mutant of LAC275
Resistant  > 500 IU nisin ml-1 
Sensitive ≤ 50 IU nisin ml-1
Sensitive 50-500 IU nisin ml-1
Crop isolates
Type strain for FAME analysis
Type strain for FAME analysis
Crop isolates
Salivaricin 47 producer
Crop isolates
Bacteriocin OR-7 producer
Crop isolates
Crop isolate
Crop isolate
Crop isolate
Crop isolate
Crop isolate
Crop isolates
Nisin- sensitive indicator strain
Indicator strains for detection 
of antagonistic activity of L. 
salivarius strains
I
I
III
I
I
I
I
I
I
I
I
I
I
I,III
II
II
III
III
III
III
III
III
III
III,IV
IV
IV
III
III
III
III
III
III
III
I
IV
Valio Ltd, Graeffe et al.1991
NIZO, Kuipers et al. 1993 
NIZO, Kuipers et al. 1998
Ra et al. 1996
Qiao et al. 1996  
Koponen et al. 2002
Qiao et al. 1996  
This study 
This study 
This study
Gasson 1984
Kuipers et al. 1995
Reunanen and Saris 2003 
Hakovirta et al. 2006
This study 
This study 
This study
This study 
This study 
This study
Christian Hansen Culture
Collection, Denmark
American Type Culture 
Collection
This study 
This study 
This study 
Stern et al. 2006
This study
 
This study 
This study
This study 
This study 
This study 
This study
National Collection of 
Industrial and Marine 
Bacteria, UK.
This study
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Table 2. Plasmids used in this study. 
Plasmid Antibiotic 
resistance
Relevant properties Used 
in
Reference
pLEB384 Ampr, Ermr lactococcal expression plasmid, P45 I Qiao et al. 1996
pKTH1984 Camr, Ermr source for nisZ probe I Graeffe et al. 1991
pLEB651 Camr lactococcal expression plasmid, PnisA II Hakovirta et al. 2006
Amp = ampicillin, Cam = chloramphenicol, r = resistance
Table 3. Sequences of PCR primers used in this study.
Primer name Sequence 5’→ 3’ Used in Original reference
pA(forward primer) AGAGTTTGATCCTGGCTCAG III Edwards et al.1989
pE (reverse primer) CCGTCAATTCCTTTGAGTTT III Edwards et al.1989
COLl (C. coli -specifi c 
primer)
AGGCA AGG GAG CCT l T A ATC IV Vandamme et al.1997
COL2 (C. coli -specifi c 
primer)
TAT CCC TAT CTA CAA ATT CGC IV Vandamme et al.1997
JUN3 (C. jejuni 
-specifi c primer)
CA TCT TCC CTA GTC AAG CCT IV Vandamme et al.1997
JUN4 (C. jejuni 
-specifi c primer)
AAG ATA TGGCTC TAG CAA GAC IV Vandamme et al.199
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6.2 Methods
A detailed description of the methods is presented in the original publications I-IV. A brief 
summary and some additional information are presented in the following chapters.
Table 4. Methods used in this study.
Methods Used in
Strain isolation and/or growth
L. lactis strains,  M17G, growth medium 
(Oxoid, Unipath Ltd, England) containing 0.5% (w/v) glucose
Lactobacillus strains, Modifi ed Lactobacillus Selective Medium, mLBS (Becton 
Dickinson Microbiology Systems, Cockeysville, MD, USA) without acetic acid.            
For bacteriocin production L. salivarius LAB 47 were grown in minimal medium 
(Stern et al., 2006)
Campylobacter jejuni Agar Base CM0689, Preston Campylobacter selective 
supplement SR0117 and lysed horse blood SR0048 (Oxoid Ltd, Finland)
I, II
III, IV
IV
IV
Induction & Identifi cation
Basic DNA techniques: DNA isolation, plasmid isolation, electrophoresis, PCR
Northern hybridization
Electrotransformation (Sambrook et al. 1989): E. coli and L. lactis (Holo and Nes 1989)
Agar diffusion test  (Tramer and Fowler 1964 )                                                                       
Partial 16S rRNA gene sequencing                                                                                                            
Alignment and identifi cation data base NCBI Blast Library (www.ncbi.nlm.nih.gov) 
Fatty acid analysis and FAME Chromatography, MIDI Inc., Newark, DE, USA.                        
Bioscreen C (Labsystem, Finland)
Nisin-induced GFP fl uorescence (Reunanen and Saris 2003) 
Nisin-induced GFPuv fl uorescence (Hakovirta et al. 2006 )
Fluorescence-activated cell sorting(FACS) 
Multiplex PCR assay  (Vandamme et al. 1997)                          
Well-diffusion assay (Schillinger and Luke 1989)
Ammonium sulphate precipitation
Solid –phase extraction (Phenomenex, Torrance, California, USA)
Tricine SDS-PAGE  
Coomassie brilliant blue staining
I-IV
I
I, III
I
III
III
III 
III
I
I,III
II
IV
IV
IV 
IV
IV
IV
6.2.1. Northern hybridization analysis 
L. lactis strains were grown to the exponential growth phase, collected by centrifugation 
and broken by sonication. RNA was isolated according to Ra and Saris (1995). Thirty 
micrograms of RNA and 3 mg RNA ladder (Gibco-BRL) were fractionated on 2% agarose 
gels containing formaldehyde. After electrophoresis the gel was soaked in water for 20 
min and then for 1 h in transfer buffer (8 mM Na2HPO4, 17 mM NaH2PO4). RNA was 
transferred to Hybond N membrane with a Bio-Rad Trans-Blot cell overnight at 250 mA 
at 4 °C. After transfer, membranes were rinsed in transfer buffer and then incubated in a 
vacuum oven at 80 ◦C for 2 h. Membranes were prehybridized for 4 h at 57 ◦C (5x SSC, 
5x Denhardt’s solution, 0.5% SDS and 200 mg denatured herring sperm DNA ml-1). After 
addition of the probe, hybridization was performed in the same buffer overnight at 57 ◦C. 
Membranes were washed for 10 min with 26 SSC/0.1% SDS at 57 ◦C, for 20 min with 16 
SSC/0.1% SDS at 57 ◦C, for 20 min with 0.56 SSC/0.1% SDS at 57 ◦C and for 20 min at 
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65 ◦C, and fi nally with 0.16 SSC/0.1% SDS at 65 ◦C. Membranes were exposed to Kodak 
X-Omat 100 fi lms at 270 ◦C overnight before developing.
Labeling of 50 ng of probe was performed with the Multiprime labeling system 
(Amersham) according to the manufacturer’s instructions, in the presence of Amersham’s 
[32P] dCTP (3000 Ci mmol-1, 111 TBq mmol-1). Free nucleotides were separated from 
labeled DNA with Sephadex C-50 Nick columns (Pharmacia). The nisZ-specifi c DNA for 
the probe was madeby digestion of plasmid pLEB1984 (Graeffe et al. 1991) with SspI and 
SacI, generating a 227 bp fragment (the ends of the fragment are at bp 125–352 in the nisZ 
sequence at EMBL accession no. Z18947), which was isolated from a 0.8% agarose gel 
using a Magic PCR prep kit (Promega).
6.2.2. Nisin bioassay
In order to detect the activity of nisin in the cytoplasm of lactococcal cells, L. lactis strains 
were grown to OD600 0.6. The cells were collected from 10 ml of culture by centrifugation 
and resuspended in 200 ml distilled water acidifi ed to pH 2.5 with HCl.
PMSF was used to irreversibly inhibit serine proteases NisP and trypsin at a fi nal 
concentration of 10 mg ml-1 when needed. For isolation of intracellular nisin the cells 
were frozen by liquid nitrogen and thawed several times prior to sonication. Cytoplasm of 
LAC85 cells was also isolated without addition of PMSF for comparison. After sonication 
using a Labsonic U (Labsystems), the particulate fraction was removed by centrifugation 
at 14 000 g for 10 min and the supernatant was further fi ltered through a membrane with a 
cut-off of 0.2 mm. Antibacterial activity of nisin was determined as growth inhibition zones 
on Luria–Bertani soft agar plates inoculated with M. luteus. The indicator strain M. luteus 
was grown to OD600 0.7 and 10 μl of the culture was added to 3 ml Luria–Bertani soft agar.
Three μl of the samples (both cells and supernatant for each strain) to be tested was 
applied as a droplet on the agar surface and allowed to dry. Plates were incubated overnight 
at 37 ◦C. The samples (both cells and supernatant) were heated at 80 ◦C for 10 min and 
stored frozen prior to the GFP bioassay.
6.2.3. GFP and GFPuv based nisin bioassays 
Two highly sensitive nisin bioassays were performed in this study as described by Reunanen 
and Saris (2003) and Hakovirta et al. (2006). The indicator strain LAC240 was used in the 
fi rst assay and LAC275 in the latter. When LAC275 was used in the GFP bioassay the 
freezing step was omitted, chloramphenicol (10 mg ml-1) was added to the growth medium 
instead of erythromycin, less nisin was used for the standard curve, and the excitation and 
emission fi lters were different. Cells of the two indicator strains were inoculated 1 : 100 in 
M17 (Oxoid) containing 0.5% (w/v) glucose, 0.1% (w/v) Tween 80; when needed, 5 mg 
ml-1 erythromycin or 10 mg ml-1 chloramphenicol was added. The indicator strain inoculum 
was divided into aliquots of 175 ml on a microplate, then 50 ml aliquots of the samples 
were applied and the nisin standards (Sigma) were prepared so that the concentration of 
nisin in the culture medium ranged from 2.5 to 125 ng ml-1 for LAC240 and from 10 to 
90 pg ml-1 for LAC275. The bacterial suspensions were divided into 225 ml aliquots on a 
microtitre plate, and incubated overnight at 30 ◦C. Before the fl uorescence measurements 
175 ml of each supernatant was removed. The maturation of newly synthesized GFP 
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molecules is a temperature-dependent process proceeding faster at low temperature (Lim et 
al. 1995). Thus, the incubated LAC240 cells were frozen for 30 min at 220 ◦C and thawed 
at room temperature prior to the detection of fl uorescence. Cells of LAC275 did not require 
freezing for correct folding due to mutations in the gfp gene (Crameri et al. 1996). Green 
protein fl uorescence was detected in terms of relative fl uorescence units (RFU) with a 
Fluoroscan Ascent 374 fl uorometer using the Ascent software (version 2.4.2; Labsystems). 
The excitation and emissions fi lters were 485 and 538 nm for LAC240, and 373 and 583 
nm for LAC275. Growth was measured by determining the OD600 with an UltrospecII 
spectrophotometer (Pharmacia LKB).
6.2.4. Fluorescence-activated cell sorting 
FACSVantage fl ow cytometer SE (BD Biosciences) was used to sort cells of the L. lactis 
LAC275 strain at the Cell Imaging Core Facility Turku in Finland. Prior to sorting, cells of 
LAC275 were grown for 24 h at 30◦C with 10 pg nisin ml-1 for induction of GFPuv.
After growth cells were diluted 1 : 1000 in PBS (0.15 M NaCl, 0.01 M sodium/
potassium phosphate buffer, pH 7.2) and analyzed with FACS using 488 nm argon laser for 
excitation and fl uorescence was detected through 530/30 nm band-pass fi lter.
Forward and side scatters and fl uorescence data were collected using logarithmic 
amplifi cation. About 2,000 events/s were analyzed with WinMDI program (version 2.8, 
Joseph Trotter http//facs.scripps.edu/).
The sorted putative mutant L. lactis LAC275 cells were cultivated on plates overnight. 
Single colonies were separately tested by GFPuv nisin bioassay (Hakovirta et al. 2006) to 
analyze any change in nisin induction of the sorted LAC275 isolates. GFPuv fl uorescence 
was measured as relative fluorescence units (RFU) with the Fluoroscan Ascent 374 
fl uorometer with Ascent software, version 2.4.2 (Labsystems).
6.2.5. Chickens and diets 
One- and 5-week-old broiler chickens with the same genetic background originating from 
the same hatchery (Broilertalo, Eura, Finland) were obtained from four Finnish farms 
(designated farm 1 [F1], in Eurajoki, F2, in Halikko, F3, in Lemu, and F4, in Marttila). The 
killing and sampling of birds were carried out under the Finnish law and statute on animal 
experiments and followed the ethical principles of the University of Helsinki.
The chickens were fed with two brands (diet A and diet B) of wheat-based diets from 
two different commercial feed manufacturers, diet A was obtained from Suomen Rehu Ltd. 
(Espoo, Finland), and diet B was obtained from Raisio Feed Ltd. (Raisio, Finland), with 
both feeds providing two different wheat-based diets according to the growth phases of the 
chickens. Starter diets (including, at day 1, Broilact [Orion Corporation, Turku, Finland]) 
were fed during the fi rst 2 weeks, followed by feeding with the grower diets. Broilact is a 
competitive exclusion preparation developed from the cecum content of chickens. Eight 
different lactobacilli have been isolated from the original inoculum, with one identifi ed as 
being L. plantarum, one as being L. salivarius, and six as being obligate anaerobes without 
identifi cation to the species level (Orion Corporation).
The main difference between diet A and diet B was that diet A was supplemented with 
salinomycin (47 mg kg of feed-1) and diet B was supplemented with naracin (50 mg kg of 
feed-1) coccidiostat during the whole feeding period. Otherwise, the diets were very similar, 
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as the differences in dry matter (6.7 and 5.6% in diet A versus 6.3 and 5.9% in diet B), total 
fat (7.5 and 7.1% in diet A versus 6.7 and 6.3% in diet B), crude protein (20% in diet A 
versus 22 and 20% in diet B), and fi ber (3 and 3.5% in diet A versus 3.6 and 3.7% in diet B) 
contents were minor.
6.2.6. Isolation and enumeration of crop bacteria
Ten chickens, at 1 and 5 weeks of age, were randomly selected from each fl ock 2 h after 
feeding and humanely killed by cervical dislocation. Whole crops were removed from the 
carcasses and transported on ice to the laboratory. The crop (n=10) contents were pooled and 
homogenized in LBS medium (1:10) in a Stomacher laboratory blender (SewardMedical, 
London, United Kingdom) for 2 min. The crop homogenate was dilutedin LBS broth and 
cultivated by spread plating and pour plating onto LBS agar.
The plates were incubated at 41.5°C for 48 h aerobically and anaerobically. For isolation 
of the crop bacteria located in the vicinity of or associated with the crop epithelium, a 1-cm2 
piece from each of the 10 chicken crops (after gravity removal of the digesta and visual 
inspection to verify a clean mucosa) was cut, placed with the internal sides towards the 
surface of the LBS agar plates, and incubated overnight at 41.5°C. Before cutting the piece 
from the crop, the crop was opened with a knife, and the crop digesta was shaken away. 
The crop digesta dropped easily away from the mucosa, as it was almost solid, revealing 
the inner epithelium of the crop as being very clean by visual inspection. Bacteria from 
the obtained lawns of the 10 crop epithelium pieces were resuspended, pooled, and diluted 
in LBS broth, followed by plating onto LBS agar in order to obtain single colonies. The 
lactobacilli of the corresponding pooled crop contents were isolated as described above.
Colonies were randomly selected and grown to pure cultures before DNA isolation.
6.2.7. Identifi cation of the crop microbiota 
Identifi cation of the crop isolates was based on partial 16S rRNA gene sequencing. To 
obtain a partial rRNA gene sequence, purifi ed chromosomal DNA (van der Meer et al. 
1993) from the isolates served as a template in PCR. The amplifi ed area was defi ned by 
universal primers pA (5’-AGA GTT TGA TCC TGG CTC AG-3’) and pE (5’-CCGTCA 
ATT CCT TTG AGT TT-3’), which hybridize to the 16S rRNA gene at nucleotides 8 to 28 
and 928 to 908 in Escherichia coli (Edwards et al. 1989). The PCR started with heating 
for 3 min at 94°C, followed by annealing for 1 min at 53°C and extension for 90 s at 72°C 
and by 30 cycles of PCR (consisting of 45 s at 94°C, 60 s at 53°C, and 90 s at 72°C) and 
ending the last cycle with storage at 4°C. One strand of the amplifi ed 900-bp fragments 
was sequenced by the Synthesis and Sequencing Laboratory (Institute of Biotechnology, 
Helsinki, Finland). Strains with 16S rRNA genes exhibiting a sequence homology of 97% 
were regarded as belonging to the same species (Drancourt et al. 2000). The sequences 
obtained were compared against the National Center for Biotechnology Information 
genome BLAST library (version 2.2.8; http://www.ncbi.nlm.nih.gov/BLAST/).
6.2.8. Fatty acid analysis and FAME chromatography of L. reuteri strains
The diversity of L. reuteri isolates was analyzed by gas chromatographic analysis of the 
whole-cell fatty acids. The extraction and derivatization method was done as described 
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previously by Miller (1982) and according to the protocol of the Sherlock microbial identi-
fi cation system (MIDI Inc.). Briefl y, approximately 40 mg (wet weight) of cells was scraped 
from the surface of the agar and transferred into a tube with a Tefl on-lined cap. Cells were 
saponifi ed by heating the cells at 100°C/30 min following the addition of 1 ml of 15% 
NaOH in 50% aqueous methanol. The hydrolysate was cooled, 2 ml of methanolic HCl 
was added, and the mixture was heated at 80°C for 10 min. The methylated fatty acids were 
quickly cooled and extracted through the addition of 1.25 ml of hexane-methyl-tert-butyl 
ether (1:1, vol/vol) with end-end mixing. The phases were allowed to separate, the lower 
aqueous layer was removed, and 3 ml of dilute NaOH was added to the remaining organic 
layer. To further clarify the phase interface, saturated NaCl was added. Approximately two-
thirds of the organic layer (containing FAMEs) was transferred to a septum-capped vial 
for analysis. MIDI gas chromatography runs were calibrated against a standard mixture of 
known fatty acids provided by MIDI. Detected sample peaks were named by interpolation 
of the retention time using the equivalent chain length method. Peaks that did not display 
equivalent chains were unnamed. Two microliters of the fatty acid methyl esters was then 
analyzed using a 5890 A gas chromatograph fi tted with a 5% phenyl methyl silicone capil-
lary column, a fl ame ionization detector, an automatic sampler, and an integrator (Agilent 
Technologies, Diegem, Belgium) with the Microbial Identifi cation system.
6.2.9. Detection of antagonistic activity of L. salivarius against C. jejuni 
L. salivarius cell-free supernatants (CFS) were obtained by centrifuging the cultures at 12 
000 x g for 10 min, collecting the supernatants, which were adjusted to pH 6.5 with 1M 
NaOH, and fi ltered through a 0.22 μm fi lter (Millipore). Inhibitory activity from hydrogen 
peroxide was avoided by the addition of catalase (5 mg ml-1). A well diffusion assay (Schil-
linger and Luke 1989) was performed by using 15 ml Campylobacter selective medium 
(Oxoid, Finland) overlaid with 1% of an overnight culture of the indicator strain mixed with 
5 ml of soft agar. Wells of 5 mm in diameter were cut into these agar plates and 25 μ1 of 
CFS of the potential producer strain was placed into well. The plates were incubated for 24 
to 48 h at 37°C in a microaerophilic atmosphere. Activity was assessed by measuring the 
diameter of the zone of inhibition formed around the CFSs loaded wells.
6.2.10. Purifi cation of the bacteriocin from the bacterial culture 
A cell-free solution (CFS) was obtained by centrifuging the 1 L -culture at 12 000 x g for 
10 min. The pH of the CFS was then adjusted to 6.5 with 1N NaOH. The proteins of 500 
ml CFS was precipitated with ammonium sulphate (45% saturation) overnight at 4°C with 
gentle stirring and centrifuged at 10 000 g for 30 min. The precipitate fraction was resus-
pended in 0.5 ml sodium phosphate buffer pH 7.2.
6.2.11. Solid phase extraction (SPE) 
Twenty μl of phosphoric acid was added to the resuspended fraction from the ammonium 
precipitation and loaded on strata-X (1 g/1 ml) column (Phenomenex, Torrance, California, 
USA).  Then, the column was washed with 10% acetonitrile in 0.1% trifl uoroacetic acid 
(TFA). Polypeptides were eluted from the column using acetonitrile/water (80:20 v/v). The 
eluted fraction (0.4 ml) was assayed for antimicrobial activity.
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6.2.12. Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
 
In order to determine which polypeptide in the elution fraction had anti-camplylobacterial 
activity a 15 μl sample was subjected to16.5% Tris-tricine-SDS-PAGE. After electrophoresis 
at 100 mA for 3 h, the gel was fi xed with a solution containing 15% ethanol and 1% acetic 
acid. The gel was then washed with distilled water for 4 h. The gel was stained with a 
solution containing 0.15% Coomassie brilliant blue R-250 (Bio-Rad) in 40% ethanol and 
7% acetic acid. Destaining was done with 10% acetic acid 3 times for 15 min. This gel with 
visible bands was further washed with phosphate-buffered saline (pH 7.2) for 1.5 h and 
then with deionized water for 3 h for the C. jejuni inhibition assay. To measure bacteriocin 
activity, the washed gel was placed onto semisolid Brucella agar (0.75% agar) overlaid 
with soft agar seeded with cells of C. jejuni SAA554, 555, 557 or 559 (Bhunia et al. 1987). 
Plates were incubated at 42°C for 48 h under a microaerobic atmosphere and inhibitory 
zones around the polypeptide bands were identifi ed.
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7. RESULTS AND DISCUSSION
7.1. Nisin induction studies (I, II)
7.1.1 The knockout of the NisT mutant L. lactis caused induction of the PnisZ promoter (I)
The regulation of nisin production by specifi c strains of Lactococcus lactis involves three 
genetically linked components: a secreted peptide pheromone, a histidine protein kinase 
(HPK) and a response regulator (RR) (Kleerebezem et al. 1997). The transmembrane HPK 
NisK senses nisin as signal, and activates the intracellular RR NisR, and subsequently 
results in activation of the nisin promoters, creating an autoinduction loop (Kuipers et al. 
1995; de Ruyter et al. 1996; Qiao et al. 1996).
Previously, Qiao and Saris (1996) reported that a L. lactis mutant with a deletion in 
the nisT gene did not secrete nisin and nisin could be detected upon lysis of these cells. 
Furthermore, complementation of this strain with a NisT encoding plasmid was suffi cient 
to restore the nisin secreting phenotype. However, in that study nisin was detected from 
cytoplasmic fraction of the NisT mutant strain, but induction of nisin promoters by 
intracellularly accumulated nisin was not investigated. In this study, we present evidence of 
a novel, nisin induction of the nisZ promoter, which functions without secretion of nisin. In 
(I) the plasmid pLEB384, which has the nisin structural gene under the control of the nisin-
inducible PnisZ and the constitutive P45 promoters, was transformed into NisT mutant LAC46 
in an attempt to achieve greater prenisin production inside the cells (LAC46/pLEB384 = 
LAC85). Northern analysis of LAC85 with a nisZ probe showed that the PnisZ promoter was 
activated without addition of extracellular nisin.
 Compared to LAC109 (the nisB mutant) and LAC108 (the nisC mutant), which contain 
unmodifi ed nisin precursor and dehydrated nisin precursor (Koponen et al. 2002), LAC85 
cells were the only cells having active nisin in the cytoplasm and the PnisZ promoter activated 
without external nisin addition. Since nisin can be found inside LAC85 cells (I), it seems 
unlikely that the induction of the PnisZ promoter observed in these cells could have been due 
to intracellular production of nisin with the leader still attached, transported by some other 
transport protein followed by cleavage by NisP. This suggests that nisin can activate the 
nisin-inducible PnisZ promoter from inside the cells. This promoter is normally activated via 
the two-component regulatory proteins NisRK, but that requires external nisin (Kuipers et 
al. 1995). Cell lysing in a culture of LAC85 would release the intracellular nisin and may 
result in nisin induction of the neighboring cells. A sensitive nisin detection method was 
needed to detect if lysis of the cells could release enough nisin for the neighboring cells to 
get induced or if another explanation is needed for the induced state of the LAB85 cells.
7.1.2. Nisin detection in the medium and the cytoplasm of L. lactis cells
To avoid the possibility that nisZ promoter activation was due to cell lysis leading to the 
release of nisin to the medium, and subsequently induction of intact cells, we determined 
the nisin content in cultures of the NisT mutant LAC85 using a sensitive nisin bioassay 
(Hakovirta et al. 2006). Cells of L. lactis LAC275 containing the nisin-inducible GFPuv gene 
were grown together with the growth supernatant of strain LAC85. The growth supernatant 
of LAC85 contained less than 10 pg nisin ml-1 (the detection limit of the assay) as the 
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supernatant was not able to induce any fl uorescence in the cells of LAC275. To ensure that 
the LAC85 cells do not release nisin to the growth supernatant for other cells to be induced, 
LAC85 cells were grown together with LAC275 cells. No GFP-related fl uorescence was 
obtained from the cell mixtures. These results indicated that the induced state of LAC85 
cells do not arise from nisin in the media released by lysed LAC85 cells. Clearly, LAC85 
cells are not inducing other cells in the surrounding as the co-growth with LAC275 should 
else have yielded induced LAC275 cells. All these results suggest that LAC85 cells can 
only induce themselves.  
In 1996 when Qiao and Saris fi rst discovered that in a NisT mutant intracellular nisin 
accumulates in the cytoplasm without the leader (later also shown by van den Bergh et 
al., 2008) the possibility for leader processing by extracellular NisP after cell breakage 
was not excluded. Therefore, to verify whether the nisin activity detected from the isolated 
cytoplasm of LAC85 was formed before or after the breakage of the cells we added the 
serine protease inhibitor PMSF to the LAC85 cells before breakage of the cells. PMSF 
should be capable of inhibiting the NisP as it is a serine protease (van der Meer et al. 1993) 
anchored on the outside of the cells. We showed that PMSF could inhibit the NisP activity 
of intact LAC85 cells. No nisin activity was detected in LAC85 cells incubated together 
with PMSF and the fully modifi ed nisin precursor still having the leader attached. To verify 
that the LAC85 cells contained active nisin and not prenisin with the leader still attached, 
the cells were broken in the presence of PMSF, to avoid the possibility that breakage of 
the cells would release nisin precursor with the leader to the NisP protease present on the 
surface of the cells, resulting in false positive results. Nisin from the cytoplasm of LAC85 
isolated in the presence of PMSF was quantifi ed using the nisin-induced green fl uorescence 
bioassay (Reunanen and Saris 2003). The results showed that the cytoplasm of LAC85 cells 
in the logarithmic growth phase (OD600 = 0.5) contained nisin at a concentration of 6.2±1.6 
ng nisin ml-1. Nisin could also be isolated from the cytoplasm of LAC85 cells that had been 
grown in the presence of PMSF. This showed that nisin with the leader attached and for 
some reason crossing the cytoplasmic membrane without NisT and potentially cleaved by 
NisP resulting in induction is not an explanation for the induced state of the LAC85 cells. 
In addition, the nisin activity of the cytoplasm of LAC85 isolated with or without 
PMSF was analyzed using nisin-sensitive M. luteus as an indicator. If the cytoplasm of 
LAC85 contained fully modifi ed nisin precursor with the leader still attached, then isolation 
of the cytoplasm without PMSF would result in cleavage of the leader, resulting in increased 
inhibition compared to cytoplasm isolated with PMSF included. The nisin activity of the 
cytoplasm of LAC85 cells +/- PMSF during isolation was in the same range (I, Fig. 2b) 
showing further that when nisin transport is blocked active nisin is accumulated in the 
cytoplasm. This has also been verifi ed in another NisT mutant (van Saparoea et al. 2008). 
7.1.3. Activation of fully modifi ed nisin precursor in the cytoplasm of L. lactis
The fact that the cytoplasm of LAC85 contains active nisin provides evidence that L. 
lactis does have intracellular proteolytic activity capable of degrading the leader from the 
fully modifi ed nisin precursor. We have not identifi ed the protease capable of nisin leader 
cleavage from the genome of the sequenced L. lactis subsp. lactis IL1403 strain (Bolotin 
et al. 2001), but the gene content of different strains may differ (Kok et al. 2005). Proteins 
have a certain half-life in cells and several proteolytic systems for this protein turnover are 
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present in all living cells. The leader has an elongated α-helical structure and could fi t into 
the proteasome and be degraded, whereas the rest of the molecule has a more rigid and 
compact structure and may not fi t into the proteasome (Groll and Clausen 2003). 
7.1.4. How does intracellular nisin induce the nisin promoters? 
One key question is how does the intracellular nisin of LAC85 cells, defi cient in nisin-
specifi c secretion capacity, reach the externally located signal recognition domain of the 
NisK?  One possibility was that the LAC85 cells had lysed, and released nisin to the intact 
cells resulting in induction of PnisZ . This possibility was excluded as nisin could not be 
detected in the culture supernatant using the sensitive nisin detection and quantifi cation 
system (Hakovirta et al. 2006), which could detect nisin in concentrations as low as 10 
pg nisin ml -1. Moreover, if the LAC85 cells released less than 10 pg nisin ml -1, then this 
concentration would not have been suffi cient to induce the nisZ promoter as strongly as 
judged from the Northern blots (I,  Fig. 1).
The possibility that nisin could to some extent be translocated to the pseudoperiplasmic 
space by transporter other than the NisT transporter cannot be excluded. In the 
pseudoperiplasmic space nisin is either adsorbed to the membrane surface or to the cell 
Figure 6. Nisin and signal recognition possibilities by NisK. A) extracellular nisin recognition 
(Kuipers et al. 1995). B) transport of nisin by ABC transporter NisFEG. 
C, D, and E are suggested locations for nisin: C) nisin adsorbs to the membrane; D) nisin inserts to 
membrane and presents the C-terminus of the molecule into the pseudoperiplasmic space for the 
NisK signal recognition domain ;E) nisin is in the pseudoperiplasmic space. 
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wall or ends up in the growth medium by diffusion or active transport. Stein et al. (2003) 
showed that the nisin ABC transporter NisFEG acts as a nisin exporter that expels nisin 
molecules from cells into surface. It seems that nisin in LAC85 is situated such that NisFEG 
cannot expel nisin to the medium as nisin could not be detected in the culture medium of 
LAC85 cells. Therefore, we suggest that in LAC85 cells, a fraction of the intracellular nisin 
is inserted into the membrane and some part of nisin is extruded to the outer side of the 
membrane and there recognized by NisK.  
 Peptide pheromones seem to use their amphiphilic C-terminal domain to bind to the 
histidine protein kinase, possibly at membrane level, in a relative non-specifi c fashion (van 
Belkum et al. (2007). The weak interaction is greatly improved by the N-terminal domain 
of the peptide pheromone that is highly specifi c for the cognate receptor. This interaction 
will enable the peptide pheromone to activate bacteriocin production at less than nanomolar 
levels. van Belkum et al. (2007) reported that the C-terminal domain of the peptide 
LV17A and enterocins A and B pheromones interact relatively non-specifi cally with the 
receptor, and that induction is greatly facilitated by the N-terminal domain that recognizes 
specifi cally its cognate receptor. The possibility that these peptide pheromones interact with 
the receptor via the membrane environment is in line with our hypothesis. 
Changes throughout the nisin molecule affect the signaling capacity, the A ring 
being essential (Dodd et al. 1996). It has been suggested that when nisin is inserted in the 
membrane the C-terminal part of the protein would not be inside the membrane and that 
the positive charge(s) would interact with the negatively charged phospholipids (van den 
Hooven et al. 1996). Additionally, charge alterations in the C-terminal part of nisin also 
resulted in a reduction of induction capacity (van Kraaij et al. 1997). Kuipers et al. (2007) 
reported that the C-terminal truncation of residues 23 to 34 reduced the induction capacity. 
Taking all the available data together, we suggest that it is the C-terminus of nisin that 
is available for NisK. The part of nisin needed for interaction with NisK may possibly stick 
out from the membrane into the aqueous pseudoperiplasmic space and be available for 
signal recognition by NisK (Fig 6). This part of nisin could well be involved in signaling 
function of nisin explaining why functional nisin inside the cells is capable of inducing the 
PnisZ promoter in the cells of LAC85. This could represent a general feature of amphiphilic 
peptides as signaling molecules in TCST pathways. The possibility that nisin interacts with 
NisK via the membrane environment is in line with the suggestion of van Belkum et al. 
(2007).
7.1.5. Isolation of natural mutants of the GFPuv nisin bioassay indicator L. lactis 
LAC275 cells by FACS(II)
In this study we aimed to test the utilization of FACS to isolate natural mutants, with 
increased sensitivity to nisin induction, of a nisin-sensing L. lactis LAC275 indicator 
GFPuv bioassay strain. No mutagenesis procedure was included prior sorting to avoid the 
risk of creating multiple mutations.
 Prior to the sorting analysis, we induced the cell with 10 pg nisin ml-1. Approximately 
10,000 cells/particles were sorted. The constructed fl uorescence histograms revealed a 
population of fl uorescing cells showing higher fl uorescence intensities than the majority of 
the nisin induced L. lactis LAC275 cells. The sorted cells were plated on two M17G plates 
(1/10 and 1/20 of the sorted cells) and grown over night at 30 C°. The viability of L. lactis 
LAC275 cells was high as the majority (>90%) of the sorted cells survived the sorting 
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conditions compared to studies of Hakkila (2006) in which only 1–10% of the Escherichia 
coli cells survived in a similar sorting. Probably, the thick cell wall is giving rigidity to the 
L. lactis cells and affects viability in the sorting conditions. Sixty-eight pure cultures were 
isolated for further analysis. Sixty-six of these cultures showed a similar responsiveness 
to nisin as the parental LAC275 strain. Two mutant L. lactis LAC275 strains, LAC344 
and LAC345, showed more sensitive linear responsiveness (0.2–0.7 pg ml-1) to nisin than 
the parental LAC275, which has a linear responsiveness in the range of 10–70 pg nisin 
ml-1. The sensitivity of LAC344 and LAC345 strains were in the same range of sensitivity 
achieved by Immonen and Karp (2007).  
 In the low nisin concentrations (0.1–0.7 pg ml-1) the parental LAC275 cells were not 
expected to show any linear responsiveness to nisin (Hakovirta et al. 2006) as was evident 
as cells of this strain got induced fi rst by nisin in concentrations above 10 pg ml-1. 
The obtained LAC344 and LAC345 strains in this study can be used as second 
generation assay strains of the GFPuv nisin bioassay for even more sensitive detection of 
nisin. Such strains are needed if the sample amount is scaled down for ‘‘lab-on-a-chip’’ 
applications.
Such compact miniaturized devices allow samples to be analyzed at the point of need 
rather than in a centralized laboratory.
    While flow cytometry is a well-established tool for the characterization of 
eukaryotic cells and their interactions, it has apparently still not reached its full potential for 
microbiological applications (Steen 2000; Longbardi Givan 2001; Link et al. 2007). In our 
study, FACS was proven to be a useful method for rapid and accurate isolation of natural 
mutants having a desired phenotype.
7.2. Applied focus: screening of bacteriocinogenic lab strains for future feeding trials 
in chicken (III, IV)
The genus Lactobacillus is essential for modern food and feed technologies. They are 
consumed by humans and fed to animals of commercial value as probiotics in efforts to 
maintain a balanced microbiota and to reduce the numbers of potential pathogens residing 
in the intestinal tract. Therefore, knowledge of the composition of chickens’ crop microbiota 
is critical for understanding the contribution of the microbiota members to the well-being of 
the avian host and for the selection of direct-fed microbials (DFM) commonly referred to as 
probiotics ( Flint and Garner 2009).
7.2.1. Characterization of the crop microbiota (III)
In this study the crop was chosen as source for future selection of candidate probiotic since 
it has been suggested that the crop microbiota acts as a bacterial inoculum for the remainder 
of the gut (Fuller 1977, Lu et al. 2003). In addition, ingested pathogens will fi rst come to 
the crop after ingestion and thereby crop could be a fi rst line of defense if it harbors anti-
pathogenic strains. Therefore, bacteria from crops of 1- and 5-week-old broiler chickens 
fed with two wheat-based diets (A and B) were grown on Lactobacillus-selective medium 
and identifi ed (n = 300) based on partial 16S rRNA gene sequence. The most abundant 
Lactobacillus species were L. reuteri (33%), L. crispatus (18.7%), and L. salivarius (13.3%) 
(I, Table 1). L. reuteri was the most abundant species (P < 0.005) in the crops of the younger 
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chickens and signifi cantly reduced in the crops of the 5-week-old chickens regardless of the 
feed (P = 0.016). The diversity of L. reuteri isolates was revealed by fatty acid analysis, 
whereas 94 L. reuteri isolates arranged into several clusters. 
Nisin has potential as a growth-promoting antibiotic (GPA). Therefore, we tested the 
nisin sensitivity of the strains of the most dominant bacteria, e. g. L. reuteri. If nisin would 
be used as a GPA it would be preferable if the strains of the most dominant specie would 
be resistant to nisin. Most of the sensitive isolates were found in younger chickens (77%) 
compared to the 5-week-old chickens (23%), whereas chickens fed with commercial feed 
B had a higher proportion of nisin-resistant isolates (73%) than did chickens fed with feed 
A (45%). The diversity of the L. reuteri population and the frequency of nisin resistant L. 
reuteri strains in the crops suggest that it could be possible to use nisin as a GPA without 
wiping out the dominant L. reuteri strains from the crop. Using nisin as a GPA could be 
combined with several strains representing different clusters and nisin resistance phenotypes 
in candidate feed supplements for chickens.
7.2.2. Characterization of L. salivarius bacteriocin which exhibit antagonistic activity 
against Campylobacter jejni (IV)
The majority of LAB of animal microbiota is believed to be benefi cial to the host. This 
study aimed at screening lactobacilli from chicken microbiota for antimicrobial activity 
against C. jejuni. Secondly, any strains exhibiting antibacterial activity were to be isolated 
and characterized for usage evaluation as bacteria potentially promoting chicken health or 
as potent anti-food-borne pathogens.
From our collection (N = 40) of crop Lactobacillus salivarius many strains produced 
antibacterial activity against C. jejuni but LAB47 showed the strongest activity and the 
broadest activity range. Therefore, it was chosen for further studies including partial 
purification of the inhibitory substance. The bacteriocin was partially purified using 
ammonium sulphate precipitation and further purified by solid phase extraction. The 
isolated peptides were run on SDS-PAGE and the obtained polypeptides were overlaid 
with a bacteriocin sensitive Campylobacter culture identifying one of the polypeptides to 
have anti-camplylobacter activity. This polypeptide named salivaricin 47 was subjected to 
molecular mass analysis showing it to have a molecular mass of approximately 3.2 kDa, 
representing a novel size for bacteriocins of L. salivarius. The anti-Campylobacter activity 
of salivaricin 47 was not affected by catalase, but was abolished by the proteolytic enzymes, 
trypsin and Proteinase K. The salivaricin 47 was heat stable (15 min at 90°C) and showed 
inhibitory activity over a wide pH range (3 to 8). 
To our knowledge, only four bacteriocins from L. salivarius isolates have been purifi ed 
and their primary structure has been characterized (Flynn et al. 2002; Stern et al. 2006; 
Busarcevic et al. 2008; Pingitore et al. 2009).
Salivaricin 47 characterized in this study is a novel bacteriocin judged from the 
approximated molecular mass (about 3.2 kDa) and may be used for improving food safety 
regarding the threat caused by Campylobacter jejuni as well as be used as a protective 
culture in the crop of chickens potentially lowering the prevalence of Campylobacter in 
chickens. To date, four bacteriocins have been previously characterized and showed to have 
potent activity against C. jejuni (Table 5).
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Table 5. Bacteriocins produced by Lactobacillus salivarius and bacteriocins with anti-C. 
jejuni activity.
Bacteriocin-producer Name of 
bacteriocin         
Molecular 
mass
kDa
Anti-
campylobacter 
activity
References
Lactobacillus salivarius
L. salivarius
L. salivarius
L. salivarius
L. salivarius
Paenibacillus polymyxa
Enterococcus durans
Enterococcus faecium
ABP-118
OR-7
LS1
Salivaricin CRL 
1328, Salα and 
Salβ
Salivaricin47
SRCAM 602
E-760
E 50–52
4.09 
5.13 
10
4.096 and 
4.33
3.20 
3.86
5.36
3.34
ND
+
ND
ND
+
+
+
+
Flynn et al. 2002 
Stern et al. 2006
Busarcevic et al. 2008
Vera Pingitore et al. 
2009
This study
Stern et al. 2005
Line et al. 2008
Svetoch et al. 2008
ND= not determined
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8. CONCLUSIONS 
The induction of the PnisZ  in LAC85 cells occurred most likely via NisK. The mechanism 
of how nisin reaches NisK from the cytoplasm is unclear, but it is possible that nisin inserts 
into the membrane and from there presents segments of the molecule into the pseudoperi-
plasmic space for the NisK signal recognition domain. This also suggests that in the wild-
type nisin producers, NisK recognizes nisin not from the water-soluble phase but from the 
membrane. This may represent a general feature of amphiphilic peptides functioning as 
self-signaling molecules in TCST pathways as has also been suggested by van Belkum et 
al. (2007).
FACS could easily be used to isolate natural mutants of L. lactis LAC275 without any mu-
tagenesis, suggesting that the sensitivity of many other bioassays based on GFPuv induced 
production, may be easily improved in a similar manner.
The obtained LAC344 and LAC345 strains can be used as second generation assay strains 
in the GFPuv nisin bioassay for even more sensitive detection of nisin. 
In this study, the most abundant Lactobacillus species in the 1- and 5-week-old chicken 
crops was L. reuteri. The diversity of the L. reuteri population suggests a need of including 
several strains representing different clusters and nisin resistance phenotypes in candidate 
probiotic feed supplements for chickens. The change in the nisin resistance of L. reuteri 
isolates with age suggests that adding nisin to feed as a potential growth promoter may 
negatively affect the L. reuteri population of young chickens, whereas this may be less in-
fl uencial in older chickens. On the other hand, the nisin-resistant L. reuteri strains isolated 
in this study could be added to nisin-containing feed fed to young chickens, thereby poten-
tially maintaining L. reuteri as part of the dominating crop microbiota. The nisin-sensitive 
L. reuteri isolates could be used as hosts for the transformation of plasmids using food-
grade nisin selection in attempts to add extra value or functions to the bacteria in the feed 
supplement. However, such strains would be defi ned as GMO in EU restricting their use to 
countries with less strict legislation. 
Feed and food safety is an important component of any new animal antimicrobial applica-
tions. The food safety problem, Campylobacter –contaminated broilers is a signifi cant risk 
factor of human campylobacteriosis and hence the control of C. jejuni in poultry would 
reduce the risk of human exposure to Campylobacter.
The chicken intestinal bacteriocin–producing  Lactobacillus salivarius are believed to func-
tion as an innate barrier against pathogens in the GIT. Salivaricin 47 is a potent bacteriocin 
against C. jejuni and has potential use as a protective culture in the crop of chickens which 
may lower the prevalence of Campylobacter in chickens.
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9. FUTURE PROSPECTS
In this study the exact location of nisin as inducer molecule was not shown.  A future goal 
is to determine if the activation of NisK by nisin in LAC85 is from nisin inserted in the 
membrane, nisin on the membrane surface or from soluble nisin in the pseudoperiplasmic 
space. One way to study this would be to use different mutants expressing nisin instead 
of the wild-type nisin and measure changes in nisin induction in relation to differences in 
hydrophilicity of the expressed nisin mutants. 
The mutant strains LAC344 and LAC345 (II) are natural mutants affecting some unknown 
factor leading to improved nisin sensitivity when the strains are used in the nisin GFPuv 
bioassay. One future prospect is to identify the mutations and analyze the mechanism by 
which these mutations affect the nisin sensitivity of the bioassay strains. The mutations may 
be isolated by cloning fragments from LAC85 into LAC275 and screen for effects on nisin 
induced fl uorescence. 
The results in study III open up the possibility for feed studies adding nisin to the feed 
together with nisin resistant strains.  A good CE preparation may require several strains and 
species. The three most common species in the chicken crop were L. reuteri, L. crispatus 
and L. salivarius, but nisin resistant strains were only screened among the L. reuteri isolates 
(III). Therefore, nisin resistant strains need to be identifi ed among the L. crispatus and L. 
salivarius strains. Then, the feeding study with nisin and nisin resistant strains can begin.
The anti-campylobacter activity of the chicken crop strain L. salivarius 47 urges further 
characterization. The isolated bacteriocin needs to be purifi ed in higher quantities for 
detailed characterization including N-terminal amino acid sequencing, mass analysis, 
specifi c activity and spectrum of activity. A future prospect is also to clone the corresponding 
gene and eventual specifi c genes involved in biosynthesis of salvaricin 47. All such data 
would help to evaluate the potential of this bacteriocin in applications aiming at using the 
producer strain or the bacteriocin to improve food safety. 
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